"",PDXSource,Contributor,ContributorPDX.ID,PDMR.Patient.ID,Gender,CTEP.SDCCode,CTEP.SDCDescription,DiagnosisSubtype,Disease.BodyLocation,Age.atDiagnosis,Date.ofDiagnosis,Has.KnownMetastaticDisease,Grade.StageInformation,PatientNotes,Molecular.andIHC.Data,Has.Smoked100.Cigarettes,Race,Ethnicity,AdditionalMedicalHistory,Submission
1,PDXNet Consortium Members,MDACC,B8174,K42829,Female,10009951,Adenocarcinoma - colon,adenocarcinoma of sigmoid colon,Digestive/Gastrointestinal,48,42790,Yes,Stage,"Tumor Grade/Stage: Stage IV Location of known metastases: Pelvis, omentum, Chest wall (left), Lymph node (left axillary)",APC c.4037C>G p.S1346*; FBXW7 c.832C>T p.R278*; KRAS c.38G>A p.G13D; TP53 c.427G>A p.V143M,No,White,Not Hispanic or Latino,-,2021-09-02T00:00:00Z
2,PDXNet Consortium Members,MDACC,B8175,K30337,Female,10009951,Adenocarcinoma - colon,adenocarcinoma,Digestive/Gastrointestinal,26,42500,Yes,Stage,"Tumor Grade/Stage: Stage IV, poorly differentiated Location of known metastases: Peritoneum, Liver","KRAS/NRAS WT,BRAF mutated, MSI Stable",No,White,Hispanic or Latino,"Family h/o: 2nd degree relative, Uterine cancer",2018-12-19T00:00:00Z
3,PDXNet Consortium Members,MDACC,B8176,K45526,Female,10009951,Adenocarcinoma - colon,Lynch syndrome; mucinous and signet ring cell adenocarcinoma,Digestive/Gastrointestinal,41,42132,Not Reported,TNM (Pathological),"Tumor Grade/Stage:  pT1bpN0pM0, poorly differentiated Location of known metastases: Liver, Abdomen","Germline heterozygous MSH2 c388_389del variant (deleterious) Lynch syndrome, MSI-high; KRAS-G12D; Loss of MSH2 and MSH6;",Yes,White,Hispanic or Latino,"Family History: 1st degree relative, GI cancer involving esophagus, liver, bile duct, stomach, pancreas, colon, rectum",2018-12-19T00:00:00Z
4,PDXNet Consortium Members,MDACC,B8182,K75566,Female,10009951,Adenocarcinoma - colon,poorly differentiated mucinous and signet ring cell adenocarcinoma,Digestive/Gastrointestinal,54,42644,Yes,"Stage, TNM",Tumor Grade/Stage: Stage III T4N2M0 Location of known metastases: Liver,-,No,White,Hispanic or Latino,-,2021-09-02T00:00:00Z
5,PDXNet Consortium Members,MDACC,B8183,K83548,Male,10009951,Adenocarcinoma - colon,adenocarcinoma,Digestive/Gastrointestinal,46,42184,Yes,Stage,"Tumor Grade/Stage: Stage IV, moderately differentiated  Location of known metastases:  Liver, Duodenum, Pelvis",MSI-Stable; BRAF mutant; KRAS wild type,Yes,Not Provided,Not Provided,-,2018-12-19T00:00:00Z
6,PDXNet Consortium Members,MDACC,B8207,K49395,Male,10009951,Adenocarcinoma - colon,Sigmoid,Digestive/Gastrointestinal,70,41537,Yes,"Stage, TNM","Tumor Grade/Stage: Stage IVB, TxNxM1b, Moderately differentiated  Location of known metastases: Liver, Lung","Mutations present in: MDM4, NOTCH1, RB1, TP53, APC",Yes,White,Not Hispanic or Latino,No family history of cancer,2021-09-02T00:00:00Z
7,PDXNet Consortium Members,MDACC,B8209,K95634,Female,10009951,Adenocarcinoma - colon,sigmoid,Digestive/Gastrointestinal,45,42148,Yes,"Stage, TNM","Tumor Grade/Stage: Stage IVC, cTXcNXcM1c Location of known metastases: Peritoneum, Ovaries, Liver","PIK3CA-p.C420R; Mutations present in: NRAS, APC, TP53",Yes,White,Not Hispanic or Latino,"Family history: 2nd degree relative, Stomach cancer",2021-09-02T00:00:00Z
8,PDXNet Consortium Members,MDACC,B8214,K93967,NA,10009951,Adenocarcinoma - colon,sigmoid,Digestive/Gastrointestinal,38,43009,Yes,"Stage, TNM","Tumor Grade/Stage: Stage IVA , TxNxM1a, Moderately differentiated  Location of known metastases: Liver",Mutation present in:APC,No,White,Not Hispanic or Latino,-,2021-09-02T00:00:00Z
9,PDXNet Consortium Members,MDACC,B8225,K09588,Female,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,44,43218,Not Reported,"Stage, TNM (Clinical)","Tumor Grade/Stage: Stage IVA, cM1a, Moderate to poorly differentiated  Location of known metastases: Liver, Lung",BRAF-V600E,No,White,Not Hispanic or Latino,"Family history: 1st Degree relative, Leukemia; 2nd Degree relative, Colon Cancer; 2nd Degree relative, Leukemia",2021-09-02T00:00:00Z
10,PDXNet Consortium Members,MDACC,B8226,K04809,Male,10038045,Adenocarcinoma - rectum,invasive,Digestive/Gastrointestinal,60,42170,Yes,None Provided,"Tumor Grade/Stage: Stage IV, moderately differentiated  Location of known metastases: Lung, Liver","KRAS-G12A, KRAS-Q61H,  PIK3CA-p.E545A,  BRAF-S446A; Mutations present in: APC, TP53, KIT, BRCA2, NF1, AR, MAP2K2",Yes,White,Not Hispanic or Latino,"Family history: 1st degree relative, Genitourinary cancer; 1st degree relative, Unknown cancer",2021-09-02T00:00:00Z
11,PDXNet Consortium Members,MDACC,B8237,K37565,Male,10009951,Adenocarcinoma - colon,Invasive,Digestive/Gastrointestinal,46,43401,Yes,"Stage, TNM (Clinical)","Tumor Grade/Stage: Stage IVA, cT3cN1bcM1a Location of known metastases: Liver","BRAF-V600E, CHEK1 mutant",No,Not Provided,Hispanic or Latino,"Family history: 2nd degree relative, Lung ca; 2nd degree relative, Colon ca; 2nd degree relative, prostate ca",2021-09-02T00:00:00Z
12,PDXNet Consortium Members,MDACC,B8239,K86973,Female,10009951,Adenocarcinoma - colon,"Ulcerated, invasive, mucinous",Digestive/Gastrointestinal,48,43259,Yes,None Provided,"Tumor Grade/Stage: Path: T4bN1bM1, Stage IV. Clinic: Stage IVC, cTXcNXpM1c. moderately differentiated Location of known metastases: Liver","KRAS-G12C.  Mutations present in: PIK3CA, SMAD4, ALK",No,White,Declined to answer,"Family history: 1st degree relative: Multiple myeloma; 2nd degree relative, Gastrointestinal ca",2021-09-02T00:00:00Z
13,PDXNet Consortium Members,MDACC,B8255,K69718,Male,10010029,"Colorectal cancer, NOS",rectal adenocarcinoma,Digestive/Gastrointestinal,44,41647,Yes,None Provided,"Tumor Grade/Stage: Stage IIC, rcT4bcN0cM0, Moderately/ poorly differentiated  Location of known metastases: Lung, retroperitoneum Recurrent to Lung","Mutations present in: ERBB3, FBXW7, AKT1, TP53",No,White,Not Hispanic or Latino,"Family history of: 1st degree relative, Melanoma",2021-09-02T00:00:00Z
14,PDXNet Consortium Members,BCM,BCM-15003,K43809,Female,10006285,"Breast cancer, NOS","TNBC, Adenoid cystic carcinoma",Breast,66,-,Not Reported,"Grade, Stage, TNM","Tumor Grade/Stage: pT1cN0Mx, Stage IA, Grade 3","ER-, PR-, Her2-, BRCA1/2 wild type",Not Provided,Not Provided,Hispanic or Latino,Adenoid cystic carcinoma of the breast,2019-04-24T00:00:00Z
15,PDXNet Consortium Members,BCM,BCM-15006 (355-T),K78447,Female,10006190,Invasive breast carcinoma,"TNBC, infiltrating ductal",Breast,-,-,Not Reported,Grade,"Tumor Grade/Stage: Grade 3 Location of known metastasis: Bone, Skin","ER-, PR-, Her2-, BRCA1/2 wild type",Not Provided,White,Not Hispanic or Latino,-,2019-03-19T00:00:00Z
16,PDXNet Consortium Members,BCM,BCM-15008,K59650,Female,10006190,Invasive breast carcinoma,"TNBC, infiltrating ductal",Breast,-,-,Yes,TNM,"Tumor Grade/Stage: T2N3a, Grade 3 Location of known metastasis: Skin, Pleura","ER-, PR-, Her2-",Not Provided,White,Not Hispanic or Latino,-,2019-03-19T00:00:00Z
17,PDXNet Consortium Members,BCM,BCM-15029,K36641,Female,10006190,Invasive breast carcinoma,"TNBC, infiltrating ductal",Breast,-,-,Not Reported,TNM,"Tumor Grade/Stage: cT2N0M0, Grade 3","ER-, PR-. Her2-, BRCA1/2 wild type",Not Provided,White,Hispanic or Latino,"Two primary lesions, collection from second primary",2019-03-19T00:00:00Z
18,PDXNet Consortium Members,BCM,BCM-15034,K93097,Female,10006190,Invasive breast carcinoma,"Infiltrating ductal, adenocarcinoma",Breast,-,-,Yes,"Grade, Stage, TNM","Tumor Grade/Stage: T1cN1M0, Stage IB, Grade 2, Moderately Differentiated Location of known metastasis: Bone, Liver","BRCA1/2 wild type; Metastatic site, 64yo, ER+, PR-, Her2+ (primary tumor, 62yo, Her2-)",Not Provided,White,Not Hispanic or Latino,-,2019-03-19T00:00:00Z
19,PDXNet Consortium Members,BCM,BCM-15046 (122-T),K78447,Female,10006190,Invasive breast carcinoma,"TNBC, infiltrating ductal",Breast,-,-,Not Reported,Grade,"Tumor Grade/Stage: Grade 3 Location of known metastasis: Bone, Skin","ER-, PR-, Her2-, BRCA1/2 wild type",Not Provided,White,Not Hispanic or Latino,-,2019-03-19T00:00:00Z
20,PDXNet Consortium Members,BCM,BCM-15051,K03247,Female,10006190,Invasive breast carcinoma,"TNBC, ductal",Breast,59,-,Not Reported,"Grade, Stage, TNM","Tumor Grade/Stage: cT4bN2aM0, Stage 3B, Grade 3","ER-, PR-, Her2-",Not Provided,White,Not Hispanic or Latino,-,2019-04-24T00:00:00Z
21,PDXNet Consortium Members,BCM,BCM-15057,K92577,Female,10006190,Invasive breast carcinoma,Infiltrating ductal,Breast,80,-,Yes,"Grade, Stage, TNM","Location of known metastases: Bone, Liver, Lung Tumor Grade/Stage: pT2N2a, Stage IIIA, Grade 3","ER+, PR-. Her2-",Not Provided,Not Provided,Hispanic or Latino,-,2019-04-24T00:00:00Z
22,PDXNet Consortium Members,BCM,BCM-15100,K76610,Female,10006190,Invasive breast carcinoma,-,Breast,38,-,Yes,None Provided,"Recurrent disease Location of known metastases: Bone, liver","ER+, Her2-",Not Provided,White,Not Hispanic or Latino,Recurrent disease 42yo,2019-04-24T00:00:00Z
23,PDXNet Consortium Members,BCM,BCM-15115,K33807,Female,10006190,Invasive breast carcinoma,-,Breast,63,-,Not Reported,"Grade, Stage, TNM","Location of known metastases: Bone, Liver, Lung Tumor Grade/Stage: pT2N2a, Stage IIIA, Grade 3","ER+, PR-, Her2-",Not Provided,Not Provided,Hispanic or Latino,-,2019-04-24T00:00:00Z
24,PDXNet Consortium Members,BCM,BCM-3277,K53660,Female,10006190,Invasive breast carcinoma,Infiltrating duct carcinoma,Breast,39,39448,Not Reported,"Grade, Stage, TNM (Pathological)","Tumor Grade/Stage: pT1aN0MX, Stage I, Grade 3","ER+, PR+, Her2-; possible transition to TNBC",Not Provided,Not Provided,Hispanic or Latino,-,2019-01-16T00:00:00Z
25,PDXNet Consortium Members,BCM,BCM-3469,K89346,Female,10006190,Invasive breast carcinoma,"TNBC, Infiltrating duct carcinoma",Breast,36,41431,Not Reported,"Grade, Stage, TNM (Pathological)","Tumor Grade/Stage: pT4bN0MX, Stage IIIB, Grade 3","ER-, PR-, Her2-, BRCA1 mutant",Not Provided,Not Provided,Hispanic or Latino,-,2019-01-16T00:00:00Z
26,PDXNet Consortium Members,BCM,BCM-3561,K13177,Female,10006285,"Breast cancer, NOS",Lobular carcinoma,Breast,56,41640,Yes,"Stage, TNM (Clinical)","Tumor Grade/Stage: Stage IV, cT2N1, moderately differentiated Location of known metastases: Bone, NOS, Liver, Abdomen, NOS, Other: Specify in notes, Peritoneal cavity, Chest wall, NOS","Her2-, ER+, PR+,",Not Provided,White,Not Provided,History of: Lobular carcinoma NOS (56yo),2019-01-16T00:00:00Z
27,PDXNet Consortium Members,BCM,BCM-3611,K59656,Female,10006190,Invasive breast carcinoma,"TNBC, Infiltrating duct carcinoma",Breast,58,39448,Not Reported,Grade,Tumor Grade/Stage: Grade 2,"ER-, PR-, Her2-",Not Provided,Black or African American,Not Provided,-,2019-01-16T00:00:00Z
28,PDXNet Consortium Members,BCM,BCM-3887,K53706,Female,10006190,Invasive breast carcinoma,"intraductal, TNBC",Breast,27,-,Yes,"Grade, TNM (Pathological)","Recurrent Disease (local) Tumor Grade/Stage: pT2, Grade 2 Location of known metastases: bone, liver, brain, lung, chest wall","ER-, PR-, Her2-, BRCA1 mutant",Not Provided,Black or African American,Not Hispanic or Latino,-,2019-02-21T00:00:00Z
29,PDXNet Consortium Members,BCM,BCM-3936,K78243,Female,10006190,Invasive breast carcinoma,"TNBC, infiltrating ductal",Breast,44,39753,Not Reported,"Grade, Stage, TNM (Pathological)","Tumor Grade/Stage: pT2N0MX, Stage IIIA, Grade 3","ER-, PR-, Her2-",Not Provided,Not Provided,Hispanic or Latino,-,2019-02-21T00:00:00Z
30,PDXNet Consortium Members,BCM,BCM-3963 (077-R),K74091,Female,10006190,Invasive breast carcinoma,Infiltrating ductal,Breast,31,-,Not Reported,None Provided,"Tumor Grade/Stage: pT2NXcM1, Stage IV, Grade 3 Location of known metastases: brain","ER-, PR-, Her2+",Not Provided,Not Provided,Hispanic or Latino,-,2019-02-21T00:00:00Z
31,PDXNet Consortium Members,BCM,BCM-4013,K85856,Female,10006190,Invasive breast carcinoma,"TNBC, infiltrating ductal",Breast,46,-,Not Reported,None Provided,"Tumor Grade/Stage: pT3N1miMX, Stage IIIA, Grade 3","ER-, PR-, Her2-",Not Provided,Black or African American,Not Hispanic or Latino,-,2019-02-21T00:00:00Z
32,PDXNet Consortium Members,BCM,BCM-4169 (176-R),K74091,Female,10006190,Invasive breast carcinoma,Infiltrating ductal,Breast,31,-,Not Reported,None Provided,"Tumor Grade/Stage: pT2NXcM1, Stage IV, Grade 3 Location of known metastases: brain","ER-, PR-, Her2+",Not Provided,Not Provided,Hispanic or Latino,-,2019-02-21T00:00:00Z
33,PDXNet Consortium Members,BCM,BCM-4175,K83835,Female,10006190,Invasive breast carcinoma,"TNBC, infiltrating ductal",Breast,60,-,Yes,"Grade, Stage, TNM (Pathological)","Tumor Grade/Stage: pT2N1aMX, Stage IIB, Grade 3 Location of known metastases: Liver","ER-, PR-, Her2-",Not Provided,Not Provided,Hispanic or Latino,-,2019-02-21T00:00:00Z
34,PDXNet Consortium Members,BCM,BCM-4195,K83048,Female,10006190,Invasive breast carcinoma,"TNBC, infiltrating ductal",Breast,-,-,Not Reported,"Grade, Stage, TNM (Pathological)","Tumor Grade/Stage: pT3N0MX, Stage IIB, Grade 3","ER-, PR-, Her2-",Not Provided,Not Provided,Hispanic or Latino,-,2019-02-21T00:00:00Z
35,PDXNet Consortium Members,BCM,BCM-4272 (225-R),K55567,Female,10006190,Invasive breast carcinoma,"TNBC, infiltrating ductal",Breast,-,-,Yes,"Grade, Stage, TNM (Clinical)","Tumor Grade/Stage: cT4N2M1, Stage 4, Grade 3 Location of known metastases:  Brain, liver, ovary, chest wall, lung","ER-, PR-, Her2-",Not Provided,Not Provided,Hispanic or Latino,-,2019-02-21T00:00:00Z
36,PDXNet Consortium Members,BCM,BCM-4664,K67735,Female,10006190,Invasive breast carcinoma,"TNBC, infiltrating ductal",Breast,-,-,Not Reported,"Grade, Stage, TNM (Clinical)","Tumor Grade/Stage: cT3N0M0, Stage IIb, Grade 3","ER-, PR-, Her2-",Not Provided,Black or African American,Not Hispanic or Latino,-,2019-02-21T00:00:00Z
37,PDXNet Consortium Members,BCM,BCM-4849 (028-R),K55567,Female,10006190,Invasive breast carcinoma,"TNBC, infiltrating ductal",Breast,-,-,Yes,"Grade, Stage, TNM (Clinical)","Tumor Grade/Stage: cT4N2M1, Stage 4, Grade 3 Location of known metastases:  Brain, liver, ovary, chest wall, lung","ER-, PR-, Her2-",Not Provided,Not Provided,Hispanic or Latino,-,2019-02-21T00:00:00Z
38,PDXNet Consortium Members,BCM,BCM-4888,K34888,Female,10006190,Invasive breast carcinoma,"Intraductal, micropapillary",Breast,-,-,Not Reported,"Grade, Stage, TNM (Pathological)","Tumor Grade/Stage: pT3N3aMX, Stage IIIC, Grade 3 Location of known metastases: Liver, Lung","ER+, PR+, Her2+",Not Provided,Not Provided,Hispanic or Latino,-,2019-03-07T00:00:00Z
39,PDXNet Consortium Members,BCM,BCM-4913 (049-T),K04218,Female,10006190,Invasive breast carcinoma,"ductal, TNBC",Breast,37,-,Not Reported,"Grade, Stage, TNM (Pathological)","Tumor Grade/Stage: pT4N3a, Stage IIIC, Grade 3 (at 160-R resection)","ER-, PR-, Her2-, BRCA1 mutated",Not Provided,Black or African American,Not Hispanic or Latino,Recurrent at primary site at age 38.5,2019-03-07T00:00:00Z
40,PDXNet Consortium Members,BCM,BCM-5097,K52850,Female,10006190,Invasive breast carcinoma,Infiltrating ductal,Breast,-,-,Not Reported,"Stage, TNM (Clinical)","Tumor Grade/Stage: cT4N1, Stage IIIb Location of known metastases: Bone, Lung","ER+, PR+, Her2-, BRCA1 wildtype, BRCA2 mutant",Not Provided,White,Not Provided,-,2019-03-07T00:00:00Z
41,PDXNet Consortium Members,BCM,BCM-5156,K65982,Female,10006190,Invasive breast carcinoma,"TNBC, infiltrating ductal",Breast,-,-,Not Reported,None Provided,"Tumor Grade/Stage: pT3N1MX, Stage IIIA, Grade 3","ER-, PR-, Her2-, BRCA1 wild type, BRCA2 wild type",Not Provided,Not Provided,Hispanic or Latino,-,2019-03-07T00:00:00Z
42,PDXNet Consortium Members,BCM,BCM-5438 (160-R),K04218,Female,10006190,Invasive breast carcinoma,"ductal, TNBC",Breast,37,-,Not Reported,"Grade, Stage, TNM (Pathological)","Tumor Grade/Stage: pT4N3a, Stage IIIC, Grade 3 (at 160-R resection)","ER-, PR-, Her2-, BRCA1 mutated",Not Provided,Black or African American,Not Hispanic or Latino,Recurrent at primary site at age 38.5,2019-03-07T00:00:00Z
43,PDXNet Consortium Members,BCM,BCM-5471,K11985,Female,10006190,Invasive breast carcinoma,"ductal, TNBC",Breast,-,-,Not Reported,"Grade, Stage, TNM","Tumor Grade/Stage: pT2N2a, Stage IIIA, Grade 3 Location of known metastases: chest wall","ER-, PR-, Her2-",Not Provided,Not Provided,Hispanic or Latino,-,2019-03-12T00:00:00Z
44,PDXNet Consortium Members,BCM,BCM-5998,K84947,Female,10006190,Invasive breast carcinoma,"TNBC, Infilitrating ductal",Breast,47,-,Not Reported,"Grade, Stage, TNM","Tumor Grade/Stage: pT2N0MX, Stage IIA, Grade 3 Recurrence: primary Location of known metastases: Bone, chest wall, lung",-,Not Provided,White,Not Hispanic or Latino,-,2019-03-12T00:00:00Z
45,PDXNet Consortium Members,BCM,BCM-6257,K38179,Female,10006190,Invasive breast carcinoma,"TNBC, infiltrating ductal",Breast,-,-,Not Reported,"Grade, Stage, TNM","Tumor Grade/Stage: cT1N0M0, pT1bN0, Stage 1A, Grade 3","ER-, PR-, Her2-",Not Provided,White,Hispanic or Latino,-,2019-03-12T00:00:00Z
46,PDXNet Consortium Members,BCM,BCM-8563,K91053,Female,10006190,Invasive breast carcinoma,"TNBC, Infiltrating ductal",Breast,-,-,Not Reported,"Grade, Stage, TNM (Pathological)","Tumor Grade/Stage: pT2N0MX, Stage IIA, Grade 3","ER-, PR-, Her2-, BRCA1/2 wild type",Not Provided,Not Provided,Hispanic or Latino,"Later collection ER-, PR+, Her2-",2019-03-12T00:00:00Z
47,PDXNet Consortium Members,BCM,BCM-9161,K32407,Female,10006190,Invasive breast carcinoma,Infiltrating ductal,Breast,-,-,Not Reported,"Grade, Stage, TNM","Tumor Grade/Stage: cT3N0M0, Grade IIb, Grade 3","ER+, PR-, Her2-, BRCA1 mutant, BRCA2 wild type",Not Provided,Not Provided,Hispanic or Latino,-,2019-03-12T00:00:00Z
48,PDXNet Consortium Members,MDACC,BCX.141,K03042,Female,10006190,Invasive breast carcinoma,invasive lobular carcinoma,Breast,38,40238,Yes,None Provided,"Tumor Grade/Stage: Stage II Location of known metastases: liver, axillary lymph nodes","Initial dx: ER/PR +, HER2 -; Recurrence: ER+,PR-, HER2- by FISH",No,White,Not Hispanic or Latino,Family history: 1st degree relative: Thyroid ca,2020-12-22T00:00:00Z
49,PDXNet Consortium Members,MDACC,BCX.142,K34492,Female,10006190,Invasive breast carcinoma,-,Breast,39,43004,Not Reported,None Provided,Tumor Grade/Stage: Stage IIA,"ER/PR -, HER2 (1+) by IHC",Yes,White,Not Hispanic or Latino,Family history: 1st Degree relative: Ovarian Ca; 2nd Degree relative: Breast Ca,2020-12-22T00:00:00Z
50,PDXNet Consortium Members,MDACC,BCX.147B,K30722,Female,10006190,Invasive breast carcinoma,-,Breast,40,41697,Yes,Stage,Stage/Grade: Stage IIIA Location of known metastases: Lymph Nodes,"ER+, PR-, HER2-, ATM normal",No,Black or African American,Not Hispanic or Latino,"Family History: 1st Degree Relative, Cervical Ca; 2nd Degree Relative, Ovarian Ca; Other Relative, Bladder Ca",2020-11-23T00:00:00Z
51,PDXNet Consortium Members,MDACC,C1196,K06000,Female,10009951,Adenocarcinoma - colon,adenocarcinoma,Digestive/Gastrointestinal,43,42815,Yes,"Stage, TNM","Tumor Grade/Stage: Stage IV, pT3N0M1, moderately differentiated  Location of known metastases: Liver","KRAS (wild type), NRAS (wild type), BRAF (wild type), IHC results [MSS],",No,White,Not Hispanic or Latino,"Family history: 2nd degree relative, throat cancer",2021-09-02T00:00:00Z
52,PDXNet Consortium Members,MDACC,C1197,K57651,Male,10038045,Adenocarcinoma - rectum,-,Digestive/Gastrointestinal,31,42472,Yes,Stage,"Tumor Grade/Stage: Stage IV, moderately differentiated Location of known metastases: Liver",-,No,White,Not Hispanic or Latino,-,2019-01-15T00:00:00Z
53,PDXNet Consortium Members,MDACC,C1199,K35865,Female,10009951,Adenocarcinoma - colon,adenocarcinoma of cecum,Digestive/Gastrointestinal,38,42901,Yes,"Stage, TNM (Pathological)","Tumor Grade/Stage: Stage IV, pT3N1bM1, moderately differentiated Location of known metastases: liver","IHC results [MSS],  genetic screening [BRAF-wild type], [APC: R554*], [ATM: R805*]; [KRAS: G13D] PIK3CA: E81K",Yes,White,Not Hispanic or Latino,"Family history: 1st degree relative, Lung cancer & Lymphoma; 1st degree relative, Prostate Ca; 2nd degree relative, Breast Ca",2019-01-15T00:00:00Z
54,PDXNet Consortium Members,MDACC,C1205,K99816,Male,10038045,Adenocarcinoma - rectum,-,Digestive/Gastrointestinal,50,42772,Yes,"Stage, TNM (Pathological)","Tumor Grade/Stage: Stage IV, pT4N1M1, moderately differentiated Location of known metastases: Liver","IHC results [MSS], genetic screening [KRAS-G12D],[POLE- K1058Q], [TP53- R175H], [BRAF-wild], [NRAS-wild]",Not Provided,White,Not Hispanic or Latino,-,2019-01-01T00:00:00Z
55,PDXNet Consortium Members,MDACC,C1206,K53633,Male,10038045,Adenocarcinoma - rectum,-,Digestive/Gastrointestinal,45,43105,Yes,TNM,"Tumor Grade/Stage: T3N2M0, moderately differentiated Location of known metastases: Liver",IHC results [MSS],Yes,Asian,Not Hispanic or Latino,"Sigmoid colon and rectum Family history: 2nd degree relative: Breast ca; 2nd degree relative, Testicular ca; >=2nd degree relative Leukemia",2019-01-15T00:00:00Z
56,PDXNet Consortium Members,MDACC,C1208,K36813,Female,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,47,42786,Yes,"Stage, TNM","Recurrent disease Tumor Grade/Stage: Stage III, ypT3N1a, moderately differentiated  Location of known metastases: Liver",KRAS-G12D,Yes,White,Not Hispanic or Latino,"H/o: Cervical Cancer (1997) Family History: 2nd Degree Relative, Lymphoma and Melanoma",2019-06-19T00:00:00Z
57,PDXNet Consortium Members,MDACC,C1212,K74670,Male,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,55,43087,Yes,"Stage, TNM (Pathological)","Tumor Grade/Stage: Stage III, ypT3N2aM1a, moderately differentiated  Location of known metastases: Liver",KRAS 436G/A; SMAD1081C/T; TP53 742C/T,No,Black or African American,Not Provided,"Concurrent Diagnosis: 10/2018, Stage IV Carcinoma of the Cecum Family h/o cancer: 1st degree relative, Lung cancer",2019-06-19T00:00:00Z
58,PDXNet Consortium Members,MDACC,C1215,K88310,Female,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,-,-,Yes,Stage,"Tumor Grade/Stage: Stage III, moderately differentiated  Location of known metastases: Liver",APC3925G/T; BRCA15575C>G; PIK3CA 331A>G ; TP53 817C>T,No,Black or African American,Not Hispanic or Latino,-,2019-06-19T00:00:00Z
59,PDXNet Consortium Members,MDACC,C1216,K43933,Male,10038045,Adenocarcinoma - rectum,mucinous features,Digestive/Gastrointestinal,60,42401,Yes,TNM,"Tumor Grade/Stage: T3bN1M0, moderate to poorly  differentiated Location of known metastases: Liver",KRASG12A; NOTCH3 R1100H; FBX W7 R465H,No,White,Not Hispanic or Latino,"Family h/o cancer: 1st Degree Relative, lung cancer; 1st Degree Relative, Brain and Breast cancer",2019-06-19T00:00:00Z
60,PDXNet Consortium Members,MDACC,C1217,K54147,Female,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,50,43167,Yes,TNM (Pathological),"Tumor Grade/Stage: pT2pN0, moderately differentiated  Location of known metastases: Liver Location of primary tumor: sigmoid colon","KRAS-G12V, TP53-R175H; FBXW7 S582P; PIK3CA E103_P104-del/ins-A",No,White,Not Hispanic or Latino,"Family h/o cancer: 1st Degree relative, H&N Squamous cell carcinoma; 2nd degree relative, Breast cancer",2019-06-19T00:00:00Z
61,PDXNet Consortium Members,MDACC,C1221,K39599,Male,10038045,Adenocarcinoma - rectum,-,Digestive/Gastrointestinal,38,41739,Yes,"Grade, TNM (Clinical)","Location of known metastases: liver, lung Tumor Grade/Stage: cM1; moderately differentiated",KRAS G12D,No,Not Provided,Not Provided,-,2019-08-27T00:00:00Z
62,PDXNet Consortium Members,MDACC,C1222,K70679,Female,10009951,Adenocarcinoma - colon,villoglandular,Digestive/Gastrointestinal,55,42901,Yes,"Grade, Stage",Location of known metastases: liver Recurrent disease Tumor Grade/Stage: IV; well-differentiated,APCp.Q1291* NRAS p.G12V TP53 p.G245S,Not Provided,Not Provided,Hispanic or Latino,Family h/o 1st degree relatives with breast cancer and prostate cancer,2019-08-27T00:00:00Z
63,PDXNet Consortium Members,MDACC,C1226,K82573,Male,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,67,43276,Yes,"Grade, Stage, TNM (Clinical), TNM (Pathological)",Location of known metastases: liver Recurrent disease arising in a tubulovillous adenoma w/high grade hyperplasia. Tumor Grade/Stage: IVB; moderately differentiated; pT3 pN1b cM1b,RAS A146T; G13D;  TP53 R175H CREBBP CREBBP p.R424*  FBXW7.R465C,No,Black or African American,Not Hispanic or Latino,-,2019-08-27T00:00:00Z
64,PDXNet Consortium Members,MDACC,C1228,K47016,Male,10009951,Adenocarcinoma - colon,"Invasive, cecum",Digestive/Gastrointestinal,69,43224,Not Reported,"Stage, TNM (Pathological)","Tumor Grade/Stage: Stage IVA, pM1a, moderately differentiated Location of known metastases: Liver","Mutations present it: PTCH1, TP53",Yes,White,Not Hispanic or Latino,"Family history: 1st Degree relative, Leukemia & Skin ca",2021-09-02T00:00:00Z
65,PDXNet Consortium Members,MDACC,C1229,K70241,Male,10010029,"Colorectal cancer, NOS",rectal adenocarcinoma,Digestive/Gastrointestinal,51,42461,Yes,None Provided,"Tumor Grade/Stage: ypT0, pN1c, cM0 Location of known metastases: Liver","KRAS-G12D, TP53 mutated",No,White,Not Hispanic or Latino,"Family history: 2nd degree relative, lymphoma",2021-09-02T00:00:00Z
66,PDXNet Consortium Members,MDACC,C1239,K50252,Female,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,42,42732,Yes,"Grade, Stage",Location of known metastases: liver Tumor Grade/Stage: moderately differentiated; Stage IV,APC R332; CDH M1L; KRAS G12V PIK3CA E545K,No,Asian,Not Hispanic or Latino,-,2019-08-27T00:00:00Z
67,PDXNet Consortium Members,MDACC,C1240,K10315,Male,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,55,43207,Yes,"Grade, TNM (Pathological)","Location of known metastases: liver Tumor Grade/Stage: ypT3N1b; moderately differentiated Primary tumor location: cecum, arising in a tubulovillous adenoma",KRAS p.G12C  PIK3CA p.D350G; .Q546K  APC pT p.L1488fs*26 FBXW7 p.R465C,No,Not Provided,Not Hispanic or Latino,-,2019-08-27T00:00:00Z
68,PDXNet Consortium Members,HCI,HCI-004,K92478,Female,10006190,Invasive breast carcinoma,TNBC,Breast,55,39995,Not Reported,None Provided,"Tumor Grade/Stage: Stage IIA, Grade III, Poorly differentiated","ER-, PR-, Her2-",No,White,Hispanic or Latino,-,2021-09-02T00:00:00Z
69,PDXNet Consortium Members,HCI,HCI-008,K88751,Female,10006190,Invasive breast carcinoma,-,Breast,85,39083,Yes,Stage,Tumor Grade/Stage: Stage IV Location of known metastases: Pleura,"ER-, PR-, Her2+",No,White,Not Hispanic or Latino,-,2021-09-02T00:00:00Z
70,PDXNet Consortium Members,HCI,HCI-014,K39284,Female,10006190,Invasive breast carcinoma,"TNBC, Infiltrating lobular adenocarcinoma",Breast,59,39904,Yes,"Grade, Stage","Tumor Grade/Stage: Stage IV, Grade II Location of known metastases: Bone, Pleura","ER-, PR-, HER2-; Her2 IHC (2+); Her2 not amplified (FISH)",No,White,Not Provided,-,2021-09-02T00:00:00Z
71,PDXNet Consortium Members,HCI,HCI-017,K18605,Female,10006190,Invasive breast carcinoma,ductal,Breast,53,41153,Yes,None Provided,"Location of known metastases: Brain, bone, lung","ER+, PR+, Her2-",No,White,Not Hispanic or Latino,-,2021-09-02T00:00:00Z
72,PDXNet Consortium Members,HCI,HCI-018,K80651,Female,10006190,Invasive breast carcinoma,Invasive lobular carcinoma with focal signet ring features,Breast,47,37012,Yes,Stage,"Tumor Grade/Stage: Stage IV Location of known metastases: Brain, Bone, Ovary","ER+, PR-, Her2-",No,Not Provided,Not Provided,"Disease Progression: Invasive breast carcinoma, Stage IIIA (2001); Invasive lobular carcinoma, Stage IV (2003)",2021-09-02T00:00:00Z
73,PDXNet Consortium Members,HCI,HCI-019,K18234,Female,10006190,Invasive breast carcinoma,"TNBC, IDC with apocrine features",Breast,59,41456,Not Reported,None Provided,Tumor Stage/Grade: poorly differentiated,"ER- (1%), PR- (1%), Her2-",Not Provided,Not Provided,Hispanic or Latino,-,2019-05-07T00:00:00Z
74,PDXNet Consortium Members,HCI,HCI-023,K65121,Female,10006190,Invasive breast carcinoma,TNBC,Breast,54,41640,Yes,None Provided,"Tumor Grade/Stage: Stage IIA, Grade II, Poorly differentiated Location of known metastases: Brain, Lung, Bone","ER-, PR-, Her2-",No,White,Not Hispanic or Latino,-,2021-09-02T00:00:00Z
75,PDXNet Consortium Members,HCI,HCI-028LV,K71592,Female,10006190,Invasive breast carcinoma,"TNBC, adenocarcinoma",Breast,31,40513,Yes,Stage,"Tumor Grade/Stage: Stage IV Location of known metastases: bone, pleura, brain","ER-, PR-, Her2-",Not Provided,White,Not Hispanic or Latino,"History of: ER+ (75%), PR-, Her2- in primary tumor and ER-, PR-, Her2+ in bone metastases; reported history of ER+, PR+, Her2- breast cancer micropapillary type with apocrine features",2021-09-02T00:00:00Z
76,PDXNet Consortium Members,HCI,HCI-031 (153-M),K61826,Female,10006190,Invasive breast carcinoma,"TNBC, lobular",Breast,55,39845,Yes,None Provided,"Location of known metastases: bones, liver, ovary, fallopian tubes, pleural effusion, brain","ER-, PR-, Her2-",No,White,Not Hispanic or Latino,"History of: ER+, PR+, Her2- lobular breast cancer",2021-09-02T00:00:00Z
77,PDXNet Consortium Members,HCI,HCI-031OV (305-X),K61826,Female,10006190,Invasive breast carcinoma,"TNBC, lobular",Breast,55,39845,Yes,None Provided,"Location of known metastases: bones, liver, ovary, fallopian tubes, pleural effusion, brain","ER-, PR-, Her2-",No,White,Not Hispanic or Latino,"History of: ER+, PR+, Her2- lobular breast cancer",2021-09-02T00:00:00Z
78,PDXNet Consortium Members,HCI,HCI-032 (231-R),K07497,Female,10006190,Invasive breast carcinoma,IDC with apocrine and micropapillary features.,Breast,51,42186,Yes,"Grade, Stage","Recurrent: primary site Tumor Grade/Stage: Grade 3, Stage IV Location of known metastases: brain, pelvis","ER+, PR+, Her2+",Yes,White,Not Hispanic or Latino,"DCIS is also present, cribform type, high grade",2021-09-02T00:00:00Z
79,PDXNet Consortium Members,HCI,HCI-032EI (152-X),K07497,Female,10006190,Invasive breast carcinoma,IDC with apocrine and micropapillary features.,Breast,51,42186,Yes,"Grade, Stage","Recurrent: primary site Tumor Grade/Stage: Grade 3, Stage IV Location of known metastases: brain, pelvis","ER+, PR+, Her2+",Yes,White,Not Hispanic or Latino,"DCIS is also present, cribform type, high grade",2021-09-02T00:00:00Z
80,PDXNet Consortium Members,HCI,HCI-037,K60344,Female,10006190,Invasive breast carcinoma,"TNBC, ductal",Breast,49,38353,Yes,Stage,"Recurrence at primary site Tumor Grade/Stage: Stage IIIA Location of known metastases: Femur, pleura","ER-, PR-, Her2-",Not Provided,Not Provided,Not Provided,"Original diagnosis: (2005) ER-, PR-, Her2+ (3+), Grade 2 invasive ductal breast cancer. Recurrence: (2016) ER-, PR-, Her2+ (3+) Grade 2 IDC",2019-05-21T00:00:00Z
81,PDXNet Consortium Members,HCI,HCI-040 (305-R),K12432,Female,10006190,Invasive breast carcinoma,IDC,Breast,62,38718,Yes,Stage,"Tumor Grade/Stage: Stage IV, Grade 3, T2N0M0 Location of known metastases: Lung, lymph node, femur","ER+, PR+, HER2+",Yes,White,Not Hispanic or Latino,"History:  2006: Grade 3, T2N0M0, ER+, Her2+, ductal cancer, left breast.  2010: ipsilateral recurrence IDC, poorly differentiated with lymph node invasion, ER+, PR+, Her2+.  2015: lung and LN mets present, ER+, PR+, Her2+",2021-09-02T00:00:00Z
82,PDXNet Consortium Members,HCI,HCI-040EI (244-X),K12432,Female,10006190,Invasive breast carcinoma,IDC,Breast,62,38718,Yes,Stage,"Tumor Grade/Stage: Stage IV, Grade 3, T2N0M0 Location of known metastases: Lung, lymph node, femur","ER+, PR+, HER2+",Yes,White,Not Hispanic or Latino,"History:  2006: Grade 3, T2N0M0, ER+, Her2+, ductal cancer, left breast.  2010: ipsilateral recurrence IDC, poorly differentiated with lymph node invasion, ER+, PR+, Her2+.  2015: lung and LN mets present, ER+, PR+, Her2+",2021-09-02T00:00:00Z
83,PDXNet Consortium Members,HCI,HCI-041,K96261,Female,10006190,Invasive breast carcinoma,"TNBC, metaplastic",Breast,50,43101,Not Reported,None Provided,-,"ER-, PR-, Her2-",Not Provided,White,Not Hispanic or Latino,-,2021-09-02T00:00:00Z
84,PDXNet Consortium Members,HCI,HCI-042,K74601,Female,10006190,Invasive breast carcinoma,"TNBC, ductal",Breast,42,42736,Not Reported,None Provided,-,"ER-, PR-, Her2-",Not Provided,White,Not Hispanic or Latino,-,2021-09-02T00:00:00Z
85,PDXNet Consortium Members,HCI,HCI-043 (060-T),K34576,Female,10006190,Invasive breast carcinoma,"TNBC, ductal",Breast,43,43160,Yes,None Provided,"Location of known metastases: liver, bone, ascites","ER-, PR-, Her2-",No,White,Not Hispanic or Latino,-,2021-09-02T00:00:00Z
86,PDXNet Consortium Members,HCI,HCI-044 (182-R),K29053,Female,10006190,Invasive breast carcinoma,invasive ductal carcinoma,Breast,39,41944,Yes,None Provided,"Location of metastases: Bone, pleura","ER+, PR+, Her2-",No,White,Not Hispanic or Latino,-,2021-09-02T00:00:00Z
87,PDXNet Consortium Members,HCI,HCI-044EI (152-X),K29053,Female,10006190,Invasive breast carcinoma,invasive ductal carcinoma,Breast,39,41944,Yes,None Provided,"Location of metastases: Bone, pleura","ER+, PR+, Her2-",No,White,Not Hispanic or Latino,-,2021-09-02T00:00:00Z
88,PDXNet Consortium Members,HCI,HCI-045,K88866,Female,10006190,Invasive breast carcinoma,"TNBC, ductal",Breast,36,43374,Not Reported,None Provided,-,"ER-, PR-, Her2-",No,White,Not Hispanic or Latino,-,2021-09-02T00:00:00Z
89,PDXNet Consortium Members,HCI,HCI-046,K31473,Female,10006190,Invasive breast carcinoma,"TNBC, ductal",Breast,69,43405,Not Reported,None Provided,-,"ER-, PR-, Her2-",No,White,Not Hispanic or Latino,-,2021-09-02T00:00:00Z
90,PDXNet Consortium Members,HCI,HCI-049,K64320,Female,10006190,Invasive breast carcinoma,Invasive ductal carcinoma,Breast,33,43101,Not Reported,None Provided,-,"ER+, PR+, Her2-",Yes,White,Not Hispanic or Latino,-,2021-09-02T00:00:00Z
91,PDXNet Consortium Members,HCI,HCI-051 (244-M),K34576,Female,10006190,Invasive breast carcinoma,"TNBC, ductal",Breast,43,43160,Yes,None Provided,"Location of known metastases: liver, bone, ascites","ER-, PR-, Her2-",No,White,Not Hispanic or Latino,-,2021-09-02T00:00:00Z
92,PDXNet Consortium Members,HCI,HCI-001,K55119,Female,10006190,Invasive breast carcinoma,"TNBC. IDC, papillary architecture",Breast,40,39083,Yes,"Grade, Stage","Tumor Grade/Stage: Stage 4, Grade III Location of known metastases: Lung",-,Not Provided,Not Provided,Not Provided,-,2019-06-11T00:00:00Z
93,PDXNet Consortium Members,HCI,HCI-002,K50745,Female,10006190,Invasive breast carcinoma,TNBC,Breast,61,39845,Yes,Grade,Tumor Grade/Stage:  Grade III Location of known metastases: Lymph node,"ER-, PR-, Her2-",Not Provided,Not Provided,Not Provided,-,2019-06-11T00:00:00Z
94,PDXNet Consortium Members,HCI,HCI-005 (336-M),K42072,Female,10006190,Invasive breast carcinoma,Adenocarcinoma,Breast,44,36951,Yes,Stage,"Tumor Grade/Stage: Stage IV Location of known metastases: Lung, bone, pleura","ER+, PR+, HER2-",Not Provided,Not Provided,Not Provided,-,2019-06-11T00:00:00Z
95,PDXNet Consortium Members,HCI,HCI-007 (274-M),K42072,Female,10006190,Invasive breast carcinoma,Adenocarcinoma,Breast,44,36951,Yes,Stage,"Tumor Grade/Stage: Stage IV Location of known metastases: Lung, bone, pleura","ER+, PR+, HER2-",Not Provided,Not Provided,Not Provided,-,2019-06-11T00:00:00Z
96,PDXNet Consortium Members,HCI,HCI-009,K93541,Female,10006190,Invasive breast carcinoma,"TNBC, apocrine features",Breast,43,31048,Yes,Stage,"Tumor Grade/Stage: Stage IV Location of known metastases: Lung, bone, pancreas, peritoneum","ER-, PR-, Her2-",Not Provided,Not Provided,Not Provided,-,2019-05-16T00:00:00Z
97,PDXNet Consortium Members,HCI,HCI-010,K16669,Female,10006190,Invasive breast carcinoma,TNBC,Breast,47,39083,Yes,Stage,"Tumor Grade/Stage: Lung Location of known metastases: Lung, Pleura","ER-, PR-, Her2-",Not Provided,Not Provided,Not Provided,-,2019-05-16T00:00:00Z
98,PDXNet Consortium Members,HCI,HCI-011,K91478,Female,10006190,Invasive breast carcinoma,IDC,Breast,58,39326,Yes,Stage,"Tumor Grade/Stage: Stage IV Location of known metastases: lymph node, pleura","ER+, PR+, HER2-",Not Provided,Not Provided,Not Provided,-,2019-06-11T00:00:00Z
99,PDXNet Consortium Members,HCI,HCI-012,K40892,Female,10006190,Invasive breast carcinoma,Adenocarcinoma,Breast,43,36526,Yes,None Provided,"Location of known metastases: Lymph node, pericardium","ER-, PR-, Her2 not reported",Not Provided,Not Provided,Not Provided,Biomarker assessment 2 years prior showed ER-/PR-/HER2+ disease. HER2 status was not re-tested on the pleural effusion sample used to make the PDX.,2019-06-12T00:00:00Z
100,PDXNet Consortium Members,HCI,HCI-013 (M1),K97960,Female,10006190,Invasive breast carcinoma,Invasive lobular carcinoma,Breast,53,37742,Yes,Stage,"Tumor Grade/Stage: Stage IV Location of known metastases: Liver, Lung, Pericardium","ER+, PR+, Her2-",Not Provided,Not Provided,Not Provided,-,2019-05-07T00:00:00Z
101,PDXNet Consortium Members,HCI,HCI-013EI (M2),K97960,Female,10006190,Invasive breast carcinoma,Invasive lobular carcinoma,Breast,53,37742,Yes,Stage,"Tumor Grade/Stage: Stage IV Location of known metastases: Liver, Lung, Pericardium","ER+, PR+, Her2-",Not Provided,Not Provided,Not Provided,-,2019-05-07T00:00:00Z
102,PDXNet Consortium Members,HCI,HCI-015,K90681,Female,10006190,Invasive breast carcinoma,TNBC,Breast,49,40148,Yes,Stage,Tumor Grade/Stage: Stage IV Location of known metastases: Brain,"ER-, PR-, Her2-",Not Provided,Not Provided,Not Provided,-,2019-05-16T00:00:00Z
103,PDXNet Consortium Members,HCI,HCI-016,K17667,Female,10006190,Invasive breast carcinoma,ductal,Breast,40,23163,Yes,Stage,Tumor Grade/Stage: Stage IIIb,"BRCA germline mutation, 4184del4",Not Provided,Not Provided,Not Provided,Patient history:2nd  breast cancer diagnosis but unclear if it is a recurrence or 2nd primary. Family is BRCA1+,2019-05-16T00:00:00Z
104,PDXNet Consortium Members,HCI,HCI-025,K42933,Female,10006190,Invasive breast carcinoma,"TNBC, invasive with squamous differentiation (metaplastic)",Breast,38,41275,Yes,"Grade, Stage","Tumor Grade/Stage: Stage IV, Grade 3 Location of known metastases: SVC lymph node (LN), posterior cervical LN, anterosuperior mediastinum LN, neck, chest.","ER-, PR-, Her2-",Not Provided,Not Provided,Not Provided,-,2019-06-12T00:00:00Z
105,PDXNet Consortium Members,HCI,HCI-027,K11172,Female,10006190,Invasive breast carcinoma,"TNBC, IDC",Breast,45,42614,Yes,"Grade, Stage, TNM","Tumor Grade/Stage: Grade 3, Stage IIIC, T3N3M0 Location of known metastases: Lymph node, bone, liver","ER-, PR-, Her2-",Not Provided,Not Provided,Not Provided,-,2019-06-12T00:00:00Z
106,PDXNet Consortium Members,HCI,HCI-028,K53784,Female,10006190,Invasive breast carcinoma,"TNBC, IDC",Breast,31,40513,Yes,Stage,"Tumor Grade/Stage: Stage IV Location of known metastases: Bone, Lung, Ovary, Liver, Brain","ER-, PR-, Her2-",Not Provided,Not Provided,Not Provided,"Patient history shows mixed biomarker information: Primary tumor: ER+ (75%), PR-, HER2-;  Bone metastasis: ER-, PR-, HER2+; Metastatic effusion: ER-, PR-, HER2- (TNBC).",2019-05-07T00:00:00Z
107,PDXNet Consortium Members,HCI,HCI-030,K37516,Female,10006190,Invasive breast carcinoma,"TNBC, IDC",Breast,46,36161,Not Reported,"Grade, Stage, TNM","Recurrence: primary site Tumor Grade/Stage: Stage IIA, Grade 2 (poorly differentiated), T3N3Mx","ER-, PR-, Her2-",Not Provided,Not Provided,Not Provided,"Original diagnosis 1999, recurrence 2003, recurrence 2010",2019-05-07T00:00:00Z
108,PDXNet Consortium Members,HCI,HCI-033 (244-R),K82491,Female,10006190,Invasive breast carcinoma,"TNBC, adenocarcinoma",Breast,49,38718,Yes,"Grade, Stage","Recurrence at primary site Tumor Grade/Stage: Grade 3, Stage IIB Location of known metastases: Lung","ER-, PR-, Her2-",Not Provided,Not Provided,Not Provided,"Original diagnosis (2006) ER+, PR+, Her2- DCIS Grade 2. Recurrence: (2014) Ipsilateral recurrence DCIS",2019-05-21T00:00:00Z
109,PDXNet Consortium Members,MDACC,HCI034 (001-R),K82491,Female,10006190,Invasive breast carcinoma,"TNBC, adenocarcinoma",Breast,49,38718,Yes,"Grade, Stage","Recurrence at primary site Tumor Grade/Stage: Grade 3, Stage IIB Location of known metastases: Lung","ER-, PR-, Her2-",Not Provided,Not Provided,Not Provided,"Original diagnosis (2006) ER+, PR+, Her2- DCIS Grade 2. Recurrence: (2014) Ipsilateral recurrence DCIS",2019-05-21T00:00:00Z
110,PDXNet Consortium Members,HCI,HCI-036,K73638,Female,10053130,Cystosarcoma phylloides - breast,TNBC,Breast,56,41030,Not Reported,None Provided,Recurrence at primary site,"ER-, PR-, Her2-",Not Provided,Not Provided,Not Provided,-,2019-05-16T00:00:00Z
111,PDXNet Consortium Members,HCI,HCI-038 (121-R),K23558,Female,10006190,Invasive breast carcinoma,"TNBC, ductal",Breast,49,38353,Yes,Stage,"Tumor Grade/Stage: Stage IV Location of known metastases: femur, pleura","ER-, PR-, Her2-; CHEK2 p.G342S (variant of unknown significance)",Not Provided,Not Provided,Not Provided,"Original diagnosis: (2005) ER-, PR-, Her2+ (3+), Grade 2 IDC. Recurrence: (2016) ER-, PR-, Her2+ (3+), Grade 2 breast ca",2019-05-21T00:00:00Z
112,PDXNet Consortium Members,HCI,HCI-039 (121-M),K23558,Female,10006190,Invasive breast carcinoma,"TNBC, ductal",Breast,49,38353,Yes,Stage,"Tumor Grade/Stage: Stage IV Location of known metastases: femur, pleura","ER-, PR-, Her2-; CHEK2 p.G342S (variant of unknown significance)",Not Provided,Not Provided,Not Provided,"Original diagnosis: (2005) ER-, PR-, Her2+ (3+), Grade 2 IDC. Recurrence: (2016) ER-, PR-, Her2+ (3+), Grade 2 breast ca",2019-05-21T00:00:00Z
113,PDXNet Consortium Members,UC Davis,MCJ-0001,K47484,Male,10018192,"Urothelial/bladder cancer, NOS",-,Genitourinary,-,-,Not Reported,TNM (Pathological),"Tumor Grade/Stage: pT2a, High grade",-,Not Provided,White,Not Hispanic or Latino,Limited history available,2021-09-02T00:00:00Z
114,PDXNet Consortium Members,WISTAR,MW4404-2,K20337,Male,10053571,Melanoma,-,Skin,-,-,Yes,Stage,Location of known metastasis:  lymph nodes Tumor Grade/Stage: IV,BRAF-V600E,Not Provided,Not Provided,Not Provided,-,2019-07-29T00:00:00Z
115,PDXNet Consortium Members,MDACC,PDX.003.005,K67845,Female,10053571,Melanoma,invasive,Skin,66,40210,Yes,Stage,Tumor Grade/Stage: Stage IV Location of known lesions: not provided,"TERT amp, c.504G>T p.E168D; PTEN pos by IHC",Not Provided,White,Not Hispanic or Latino,Concurrent diagnosis: DCIS of the breast,2019-03-07T00:00:00Z
116,PDXNet Consortium Members,MDACC,PDX.003.008,K08984,Male,10041834,Squamous cell carcinoma - skin,-,Skin,70,42309,Yes,None Provided,Primary Recurrence: Ear (skin) Location of known metastasis: Lymph node,-,Yes,White,Not Hispanic or Latino,"Family history: 1st degree relatives: unknown cancer, unknown cancer",2019-03-07T00:00:00Z
117,PDXNet Consortium Members,MDACC,PDX.003.010,K68440,Female,10006190,Invasive breast carcinoma,ductal,Breast,53,40238,Not Reported,Stage,Tumor Grade/Stage: Stage IV Location of known metastasis: Lymph node,"ERBB2 amp, RPS6KB1 amp, ER+(10%), PR-, HER2+ (3+)",Not Provided,White,Not Hispanic or Latino,"Family history: 1st degree relatives: breast cancer, uterine cancer, skin cancer",2019-03-07T00:00:00Z
118,PDXNet Consortium Members,MDACC,PDX.003.011,K02507,Female,10033701,Papillary thyroid carcinoma,-,Endocrine and Neuroendocrine,36,33239,Yes,Stage,Recurrent disease Location of known metastases: Lung,IHC: PTEN p.Q214 and BRAF p.V600E mutations,Not Provided,White,Not Hispanic or Latino,Tumor Stage: IV,2019-01-15T00:00:00Z
119,PDXNet Consortium Members,MDACC,PDX.003.013,K88036,Female,10006190,Invasive breast carcinoma,-,Breast,59,41275,Yes,"Stage, TNM","Tumor Grade/Stage: Stage 1, T1N0M0 Location of known metastases: Thigh (soft tissue)","ER 5%, HER2-",Not Provided,White,Not Hispanic or Latino,"Family history: 2nd degree relative, Breast Cancer",2019-04-24T00:00:00Z
120,PDXNet Consortium Members,MDACC,PDX.003.019,K64889,Female,10038045,Adenocarcinoma - rectum,-,Digestive/Gastrointestinal,62,42736,Not Reported,Stage,Tumor Stage/Grade: Stage IVA,"IHC: APC p.Q1328*, ERBB2 p.T862A",Not Provided,White,Not Hispanic or Latino,Family History of Cancer: Two 1st Degree relatives-pancreatic and colorectal: One 2nd degree relative Breast Cancer,2019-01-15T00:00:00Z
121,PDXNet Consortium Members,MDACC,PDX.003.021,K95464,Female,10046799,Leiomyosarcoma - uterus,-,Musculoskeletal,56,41852,Not Reported,None Provided,Tumor Grade/Stage: Stage IV,PTEN and p53 mutant,Not Provided,White,Not Hispanic or Latino,-,2019-04-24T00:00:00Z
122,PDXNet Consortium Members,MDACC,PDX.003.025,K74698,Female,10006190,Invasive breast carcinoma,-,Breast,56,42005,Yes,Stage,Tumor Grade/Stage: Stage IV Location of known metastasis: Chest Wall,Her2+,Not Provided,Black or African American,Not Hispanic or Latino,"Family history: 1st degree relatives: colon cancer, lung cancer, breast cancer; 2nd degree relatives: breast cancer",2019-03-07T00:00:00Z
123,PDXNet Consortium Members,MDACC,PDX.003.036,K11815,Male,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,34,40817,Yes,TNM (Pathological),"Tumor Grade/Stage: pT3N0M0, moderately differentiated Location of known metastases: Pelvis",-,Not Provided,Not Provided,Not Hispanic or Latino,"Family history: 1st degree relative, Lung cancer",2019-02-28T00:00:00Z
124,PDXNet Consortium Members,MDACC,PDX.003.069,K50866,Male,10030139,Adenocarcinoma - esophagus,-,Digestive/Gastrointestinal,61,42005,Yes,Stage,Tumor Grade/Stage: Stage IV Location of known metastasis: Liver,"Her2+, EGFR Amplification, TP53 NM_000546.5(TP53):c.524G>A p.R175H Exon 5 SNV,",Not Provided,White,Not Hispanic or Latino,"Family history: 1st degree relatives: melanoma, melanoma",2019-03-07T00:00:00Z
125,PDXNet Consortium Members,MDACC,PDX.003.070,K50210,Female,10041115,Adenocarcinoma - small intest.,-,Digestive/Gastrointestinal,39,40634,Not Reported,TNM,Tumor Grade/Stage: ypT4N0,"SMAD4 p.R361H, BRAF p.G469A",Not Provided,Black or African American,Not Hispanic or Latino,"Family history: 2nd degree relative, Bone cancer; 2nd degree relative, Breast cancer; 2nd degree relative, Lung cancer; 2nd degree relative, Breast cancer",2019-04-24T00:00:00Z
126,PDXNet Consortium Members,MDACC,PDX.003.074,K13674,Female,10038045,Adenocarcinoma - rectum,-,Digestive/Gastrointestinal,59,41704,Yes,Stage,Tumor Grade/Stage: Stage IIA Location of known metastases: lung Recurrent disease,"FBXW7 p.R367*, APC p.R213*/p.Q1378*, KRAS p.G12V, TP53 p.Y126C",Yes,Asian,Not Hispanic or Latino,"2nd degree relative, Ovarian cancer",2019-05-14T00:00:00Z
127,PDXNet Consortium Members,MDACC,PDX.003.076,K53272,Male,10052747,Adenocarcinoma - pancreas,-,Digestive/Gastrointestinal,52,42614,Yes,TNM,Tumor Grade/Stage: T2N0M0 Location of known metastases: Liver,KRAS-G12D,Not Provided,White,Not Hispanic or Latino,"Family history: 2nd Degree relative, Breast cancer; 3rd degree relative, Brain cancer",2019-05-14T00:00:00Z
128,PDXNet Consortium Members,MDACC,PDX.003.080,K28037,Male,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,60,41579,Yes,TNM,Tumor Grade/Stage: T4aN1bM0 Location of known metastases: Liver,"APC p.L387F, CTNNB1 p.S45F, ERBB2 p.R784C, KRAS p.G13C, PTEN p.R130*, RPS6KB1 p.E149*, TP53 p.R175H",Not Provided,Not Provided,Not Provided,-,2019-05-14T00:00:00Z
129,PDXNet Consortium Members,MDACC,PDX.003.087,K55356,Female,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,35,42036,Yes,Stage,Tumor Grade/Stage: Stage IV Location of known metastases: Liver,"KRAS/NRAS/BRAF wt, ERBB2 amplification, IDH1 mutation, SMAD4 loss, TOP2A amplification, TP53 mutation, CHK2-I157T mutation",Not Provided,Not Provided,Not Provided,-,2019-05-14T00:00:00Z
130,PDXNet Consortium Members,MDACC,PDX.003.090,K21392,Female,10052747,Adenocarcinoma - pancreas,-,Digestive/Gastrointestinal,61,42856,Not Reported,None Provided,Tumor Stage/Grade: Unknown,"IHC: ATM mutation, KRAS mutation",Not Provided,White,Not Hispanic or Latino,Family History of Cancer: One First Degree Relative- Lymphoma and Prostate Cancer.  Two Second Degree Relatives-Brain and Prostate Cancer,2019-01-15T00:00:00Z
131,PDXNet Consortium Members,MDACC,PDX.003.093,K60574,Male,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,68,42887,Yes,Stage,Tumor Grade/Stage: Stage IV Location of known metastases: Peritoneum,"ROS1: negative, MSI-stable, TMB: low. Mutations present in: TP53, CDK12,SDK12,SDHA,SOX9,GPR124,ATM,KRAS,APC,MSH6,SPEN, GATA6",Not Provided,Black or African American,Not Hispanic or Latino,"Family h/o: 1st Degree relative, Esophageal cancer",2019-02-28T00:00:00Z
132,PDXNet Consortium Members,MDACC,PDX.003.094,K93363,Female,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,62,42736,Not Reported,Stage,Tumor Stage: IV,"IHC: ERBB2 Amplification, APC NM_000038.5(APC):c.3982C>T p.Q1328* Exon 16 SNV, ERBB2 NM_004448.2(ERBB2):c.2584A>G p.T862A Exon 21 SNV",Not Provided,White,Not Hispanic or Latino,Family History of cancer: First degree Pancreatic and Colorectal 1 male and 1 female.  Second-degree Breast Cancer Diagnosed at 67 y.o. 1 female.,2019-01-15T00:00:00Z
133,PDXNet Consortium Members,MDACC,PDX.003.096,K85775,Male,10004669,Cholangiocar.- intra/extrahepatic,adenocarcinoma,Digestive/Gastrointestinal,33,43006,Yes,Stage,Location of known metastases: Liver  Tumor Stage: III,"TP53 mut, BRCA2 NM_000059.3(BRCA2):c.1214G>T p.G405V Exon 10 SNV, NOTCH3 NM_000435.2(NOTCH3):c.3719-1G>T",Not Provided,White,Not Hispanic or Latino,-,2019-01-15T00:00:00Z
134,PDXNet Consortium Members,MDACC,PDX.003.097,K67555,Male,10051066,Gastrointestinal stromal tumor,-,Digestive/Gastrointestinal,74,42795,Yes,None Provided,"Location of known metastases: Bile duct, liver",KITA: c.1679_1681delTTG,Yes,White,Not Hispanic or Latino,-,2019-02-28T00:00:00Z
135,PDXNet Consortium Members,MDACC,PDX.003.100,K62884,Female,10004669,Cholangiocar.- intra/extrahepatic,adenocarcinoma,Digestive/Gastrointestinal,72,43101,Not Reported,None Provided,Tumor Grade/Stage: Stage IV,-,Not Provided,Not Provided,Not Provided,-,2019-02-28T00:00:00Z
136,PDXNet Consortium Members,MDACC,PDX.003.105,K85775,Male,10004669,Cholangiocar.- intra/extrahepatic,adenocarcinoma,Digestive/Gastrointestinal,33,43006,Yes,Stage,Location of known metastases: Liver  Tumor Stage: III,"TP53 mut, BRCA2 NM_000059.3(BRCA2):c.1214G>T p.G405V Exon 10 SNV, NOTCH3 NM_000435.2(NOTCH3):c.3719-1G>T",Not Provided,White,Not Hispanic or Latino,-,2021-09-02T00:00:00Z
137,PDXNet Consortium Members,MDACC,PDX.003.116,K78675,Female,10006190,Invasive breast carcinoma,-,Breast,39,40283,Yes,Stage,"Tumor Grade/Stage: Stage IV Location of known metastases: Brain, Lymph Node (axillary)","ER+, PR+, HER2- (by FISH)",No,Asian,Not Hispanic or Latino,-,2020-11-23T00:00:00Z
138,PDXNet Consortium Members,MDACC,PDX.003.124,K08845,Female,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,43,42736,Yes,Grade,Tumor Grade/Stage: Grade IV Location of known metastases: Retroperitoneum,"BRAF-V600E, TP53-R282W",Not Provided,White,Not Hispanic or Latino,Family history: 1st degree relative: Gynecologic ca,2020-12-09T00:00:00Z
139,PDXNet Consortium Members,MDACC,PDX.003.126,K32475,Male,10041115,Adenocarcinoma - small intest.,-,Digestive/Gastrointestinal,53,40513,Yes,TNM,Tumor Grade/Stage: T3N1M0 Location of known metastases: Liver,APC NM_000038.5(APC):c.2795C>G p.S932* Exon 16 SNV Nonsense; TP53 NM_000546.5(TP53):c.742C>T p.R248W Exon 7 SNV Missense rs121912651 COSM10656,Not Provided,Not Provided,Not Provided,-,2019-02-28T00:00:00Z
140,PDXNet Consortium Members,MDACC,PDX.003.139,K26755,Female,10006190,Invasive breast carcinoma,ductal,Breast,60,41275,Not Reported,"Stage, TNM","Tumor Grade/Stage: Stage IA, pT1bN0M0 Location of known metastases: Lymph Node (axillary)","ER/PR -, HER2 1+, TP53_S183*,",Not Provided,White,Not Hispanic or Latino,Family history: 1st Degree Relative: Genitourinary Ca; 2nd Degree Relative: Breast Ca (F); 2nd Degree Relative: Prostate Ca,2020-11-23T00:00:00Z
141,PDXNet Consortium Members,MDACC,PDX.003.150,K68566,Female,10033272,"Ovarian cancer, NOS",high grade serous,Gynecologic,53,41677,Not Reported,Stage,"Tumor Grade/Stage: Stage IVB Location of known metastases: Retroperitoneum, Peritoneum","BRCA2-S2186fs*3, PIK3R1-V589fs*13, NF1-M2031K",Yes,Black or African American,Not Hispanic or Latino,"Family history: 2nd Degree Relative, Cancer NOS",2020-12-22T00:00:00Z
142,PDXNet Consortium Members,MDACC,PDX.003.162,K67434,Female,10038045,Adenocarcinoma - rectum,rectosigmoid junction,Digestive/Gastrointestinal,56,42989,Yes,Stage,"Tumor Grade/Stage: Stage IV Location of known metastases: liver, bile duct, lung","KRAS-G12D, TP53-R248W, APC-L1382fs, APC-S722fs",Yes,White,Not Hispanic or Latino,Family history: 1st Degree Relative: Ovarian Ca,2020-12-22T00:00:00Z
143,PDXNet Consortium Members,MDACC,PDX.003.167,K47512,Female,10057270,"Neuroendocrine cancer, NOS",appendix adenocarcinoma,Endocrine and Neuroendocrine,60,41244,Yes,None Provided,"Tumor Grade/Stage: Stage IV Location of known metastases: liver, retroperitoneum and peritoneum, intra-abdominal, lymph nodes","APC-T1556fs*3, APC-p.R876*, KIT-M541L, BRAF-V600E,",No,White,Not Hispanic or Latino,"Family history: 1st Degree Relative, Carcinoma NOS",2020-12-22T00:00:00Z
144,PDXNet Consortium Members,MDACC,PDX.003.219,K18162,Female,10006190,Invasive breast carcinoma,ductal,Breast,53,43040,Not Reported,Stage,Tumor Grade/Stage: Stage IV,"ER/PR+, HER2-, NOTCH1_G1476S, PIK3CA_H1047_H1048delinsRR, TP53_P142_V143del",No,Black or African American,Not Hispanic or Latino,Family History: 1st degree relative: Cervical Ca,2020-11-23T00:00:00Z
145,PDXNet Consortium Members,MDACC,PDX.003.249,K80089,Female,10033272,"Ovarian cancer, NOS",-,Gynecologic,59,40589,Yes,None Provided,Location of known metastases: Lymph node (supraclavicular),HER2/neu amplified (FISH),No,White,Not Hispanic or Latino,"Family history: 1st degree relative, Melanoma; Undefined relative, Breast Ca",2020-12-09T00:00:00Z
146,PDXNet Consortium Members,MDACC,PDX.003.303,K73754,Female,10033700,Serous endometrial adenocarcinoma,-,Gynecologic,66,42958,Yes,Stage,"Tumor Grade/Stage: Stage IVB Location of known metastases: Peritoneum, Liver","MSI-Stable, CCND1 Amplification, FGFR1 Amplification, TP53-G266E",No,White,Not Hispanic or Latino,"Family History: 1st Degree Relative, Liver/hepatobiliary cancer",2020-11-23T00:00:00Z
147,PDXNet Consortium Members,MDACC,PDX.003.311,K90737,Female,10053571,Melanoma,mucosal,Skin,73,42064,Yes,Stage,Tumor Grade/Stage: Stage IV Location of known metastases: Pelvis,"KIT-V560D, BRAF wt, NRAS wt",Yes,White,Not Hispanic or Latino,"Family History: 1st Degree Relative, Breast Ca (F); 1st Degree Relative, Pancreatic Ca; 2nd Degree Relative, Breast Ca (F)",2020-12-09T00:00:00Z
148,PDXNet Consortium Members,MDACC,PDX.003.327,K84881,Female,10006285,"Breast cancer, NOS",TNBC,Breast,23,42597,Yes,None Provided,"Tumor Grade/Stage: Stage IV Location of known metastases: Bone, Lymph Nodes, Chest soft tissue","ER-/PR-/HER- (IHC), TP53-H179R, TSC2 loss",No,White,Not Hispanic or Latino,-,2020-12-09T00:00:00Z
149,PDXNet Consortium Members,MDACC,PDX.003.330,K10420,Male,10052747,Adenocarcinoma - pancreas,-,Digestive/Gastrointestinal,57,43357,Yes,Stage,"Tumor Grade/Stage: Stage IV Location of known metastases: Peritoneum, Liver","MYC Amplified, KRAS-G12D, RAD21 Amplified, TP53-G245fs*2",No,White,Not Hispanic or Latino,"Family history: 1st degree Relative, Colorectal Ca; 2nd degree Relative, Lung Ca NOS",2020-11-23T00:00:00Z
150,PDXNet Consortium Members,MDACC,PDX.003.340,K87561,Male,10052747,Adenocarcinoma - pancreas,-,Digestive/Gastrointestinal,54,43159,Yes,Stage,Tumor Grade/Stage: Stage IV Location of known metastases: Liver,"KRAS-G12D, BRCA2-1982fs, TP53-R347*",No,White,Not Hispanic or Latino,"Family history: 2nd degree relatives: Breast Ca NOS, Melanoma",2020-12-09T00:00:00Z
151,PDXNet Consortium Members,MDACC,PDX.003.361,K36946,Female,10006285,"Breast cancer, NOS",-,Breast,60,43054,Yes,None Provided,"Tumor Grade/Stage: Stage IIA Location of known Metastases: Liver, Chest muscle, Lymph node","ER-, PR -, HER2+ (equivocal by IHC), HER2- (by FISH)",No,White,Not Hispanic or Latino,"Family history: 2nd degree relative, Uterine Ca",2020-12-22T00:00:00Z
152,PDXNet Consortium Members,MDACC,TC751,K01560,Male,10025126,Squamous cell lung carcinoma,Neuroendocrine differentiation present,Respiratory/Thoracic,67,42764,Not Reported,TNM (Pathological),Tumor Grade/Stage: pT3pN1pMx,"AR: c.19C>A p.L7M;  CREBBP: c.205C>T p.Q69; PIK3CA: c.322C>T p.R108C;  RAD51D: c.637G>C p.G213R; SMARCA4: c.2459_2464del p.Y820_E821del; TP53: c.700T>A p.Y234N. ALK, RET, and ROS1 FISH: all negative. Met amplified (Met copy number=5.9)",Yes,White,Not Hispanic or Latino,"Family h/o: 1st degree relative, Thoracic or lung cancer",2019-02-27T00:00:00Z
153,PDXNet Consortium Members,MDACC,TC755,K00718,Male,10025126,Squamous cell lung carcinoma,-,Respiratory/Thoracic,71,43104,Not Reported,None Provided,Tumor Grade/Stage: pT2a pN1,-,Yes,White,Not Hispanic or Latino,-,2019-02-27T00:00:00Z
154,PDXNet Consortium Members,MDACC,TC779,K33824,Male,10025032,Lung adenocarcinoma,-,Respiratory/Thoracic,47,43210,Not Reported,TNM (Pathological),Tumor Grade/Stage: pT1cN0M0,ALK rearrangement reported.,No,White,Not Hispanic or Latino,"Family history: Second-degree relative, Cancer NOS 9/2019: metastatic Lung Squamous Cell Carcinoma in lymph node and lung",2020-10-13T00:00:00Z
155,PDXNet Consortium Members,MDACC,TC782,K52629,Female,10025032,Lung adenocarcinoma,-,Respiratory/Thoracic,60,43193,Not Reported,TNM (Clinical),Tumor Grade/Stage: cT1c cN0 cM0,-,Yes,White,Not Hispanic or Latino,"Family history: First-degree relatives: Thoracic or lung cancer, Gynecologic cancer",2020-10-13T00:00:00Z
156,PDXNet Consortium Members,MDACC,TC791,K37454,Male,10025126,Squamous cell lung carcinoma,-,Respiratory/Thoracic,60,43259,Not Reported,TNM (Pathological),Tumor Grade/Stage:  ypT2a ypN1 ypMx,-,Yes,White,Not Hispanic or Latino,-,2019-06-19T00:00:00Z
157,PDXNet Consortium Members,MDACC,TC796,K73088,Male,10025126,Squamous cell lung carcinoma,-,Respiratory/Thoracic,62,43101,Not Reported,TNM (Pathological),Tumor Grade/Stage: ypT3 yN2 Mx,-,Yes,White,Not Hispanic or Latino,"Family history: 1st degree relative, Thoracic or Lung cancer",2019-02-27T00:00:00Z
158,PDXNet Consortium Members,MDACC,TC800,K76290,Male,10025126,Squamous cell lung carcinoma,-,Respiratory/Thoracic,72,39614,Not Reported,TNM (Clinical),Tumor Grade/Stage: cT2b cN0 M0,-,Yes,Black or African American,Not Hispanic or Latino,"Family h/o: 1st Degree Relative, Breast cancer",2019-02-27T00:00:00Z
159,PDXNet Consortium Members,MDACC,TC806,K16732,Male,10025032,Lung adenocarcinoma,-,Respiratory/Thoracic,77,43273,Not Reported,TNM,Tumor Grade/Stage:  pT3 pN1 pMx,KRAS: c.35G>A p.G12D ; TP53: c.388C>G p.L130V,Yes,White,Not Hispanic or Latino,-,2019-06-19T00:00:00Z
160,PDXNet Consortium Members,MDACC,TC809,K29478,Male,10025126,Squamous cell lung carcinoma,-,Respiratory/Thoracic,61,41518,Not Reported,TNM (Pathological),Recurrence at Primary Site Tumor Grade/Stage:pT3 pN0M0,-,Yes,Asian,Not Hispanic or Latino,"History of Thyroid Cancer (1989), Meningioma (2013)",2019-02-27T00:00:00Z
161,PDXNet Consortium Members,MDACC,TC833,K71423,Female,10029514,"Non-small cell lung cancer, NOS",Pleomorphic carcinoma,Respiratory/Thoracic,55,43404,Not Reported,TNM,Tumor Grade/Stage: ypT4 ypN0 ypMx,-,Yes,White,Not Hispanic or Latino,"Family h/o cancer: 1st degree relative (x2), Breast cancer",2019-06-19T00:00:00Z
162,PDXNet Consortium Members,MDACC,TC849,K86501,Female,10025032,Lung adenocarcinoma,-,Respiratory/Thoracic,42,41456,Not Reported,"Stage, TNM","Tumor Grade/Stage: Stage IIIA, T1N2","EGFR: c.2300_2308dupCCAGCGTGG p.A767_V769dupASV;  TP53: c.476C>A p.A159D; PD-L1 (80%) Gene Fusion: testing of ALK, NTRK1, RET, ROS1: none identified.",No,White,Not Hispanic or Latino,-,2020-10-13T00:00:00Z
163,PDXNet Consortium Members,MDACC,TC852,K87607,Female,10041071,Small cell lung cancer,-,Respiratory/Thoracic,65,43452,Yes,None Provided,Location of known metastases: Liver,IHC: EGFR: c.2240_2257del p.L747_P753delinsS;   TP53: c.578A>T p.H193L ROS1 and ALK gene rearrangement: both negative.,No,White,Not Hispanic or Latino,"Prior h/o: SCC of lung (2017); Adenocarcinoma of the lung (2018)  Family h/o cancer: 1st degree relative, Cervical cancer",2019-06-19T00:00:00Z
164,PDXNet Consortium Members,MDACC,TC858,K08837,Female,10025032,Lung adenocarcinoma,-,Respiratory/Thoracic,65,43431,Not Reported,TNM (Pathological),Tumor Grade/Stage:  pT2b N0 M0,IHC: PD-L1 negative,Yes,White,Not Hispanic or Latino,"Family h/o cancer: 2nd degree relative (x2), breast cancer",2019-06-19T00:00:00Z
165,PDXNet Consortium Members,MDACC,TC864,K78695,Female,10025032,Lung adenocarcinoma,-,Respiratory/Thoracic,59,42452,Not Reported,TNM (Pathological),Tumor Grade/Stage: T3pN3pM0,"KRAS :c.35G>T p.G12V;   MSH6 :c.1190A>G p.Y397C; PTEN :c.371G>T p.C124F;  SETD2 :c.5217_5219delinsA p.R1740fs*4; TP53 NM_000546.5(TP53):c.643A>G p.S215G; Gene rearrangement: negative for ALK, RET, ROS1;   Negative for Met amplification",Yes,White,Not Hispanic or Latino,"Family history: First-degree relative, Thoracic or Lung ca; Second-degree relative, Breast ca",2020-10-13T00:00:00Z
166,PDXNet Consortium Members,MDACC,TC870,K23151,Male,10041071,Small cell lung cancer,-,Respiratory/Thoracic,58,42881,Yes,None Provided,Location of known metastases: Liver,-,Yes,Asian,Not Hispanic or Latino,-,2020-10-13T00:00:00Z
167,PDXNet Consortium Members,MDACC,TC877,K92267,Female,10025126,Squamous cell lung carcinoma,-,Respiratory/Thoracic,69,43371,Not Reported,TNM (Clinical),Tumor Grade/Stage: ycT2acN0cM0,-,Yes,White,Not Hispanic or Latino,"Family history: 1st degree relative, Liver cancer; 1st degree relative, Vaginal cancer",2020-10-13T00:00:00Z
168,PDXNet Consortium Members,MDACC,TC883,K21817,Male,10025032,Lung adenocarcinoma,-,Respiratory/Thoracic,65,43419,Not Reported,TNM (Clinical),Tumor Grade/Stage: cT2acN1cM0,-,Yes,White,Not Hispanic or Latino,"Family history:  First degree relative: Colon cancer; Second degree relative:, Breast cancer, Melanoma; Third degree relatives: Pancreatic cancer, Renal Cancer",2020-08-10T00:00:00Z
169,PDXNet Consortium Members,MDACC,TC889,K98260,Male,10025126,Squamous cell lung carcinoma,-,Respiratory/Thoracic,71,43530,Not Reported,TNM,Tumor Grade/Stage: cT3cN0cM0,-,Yes,White,Not Hispanic or Latino,"History of Prostate Ca (2017) Family history of: 1st degree relatives, Skin Ca NOS, Skin Ca NOS; 2nd degree relative, Melanoma.",2020-12-01T00:00:00Z
170,PDXNet Consortium Members,MDACC,TC891,K48112,Female,10041071,Small cell lung cancer,-,Respiratory/Thoracic,50,43061,Yes,None Provided,Location of known metastases:  lymph nodes,-,Yes,Asian,Not Hispanic or Latino,-,2020-08-10T00:00:00Z
171,PDXNet Consortium Members,MDACC,TC895,K97266,Male,10041071,Small cell lung cancer,-,Respiratory/Thoracic,61,43136,Yes,None Provided,"Location of known metastases: lung, liver, mesenteric lymph nodes, bone",-,Yes,White,Not Hispanic or Latino,"Prior Malignancy:  High-grade neuroendocrine carcinoma, small cell type.  Dx 2017 (CTEP SDC Code 10057270)",2020-08-10T00:00:00Z
172,PDXNet Consortium Members,MDACC,TC897,K94225,Female,10025032,Lung adenocarcinoma,-,Respiratory/Thoracic,57,43549,Not Reported,TNM (Clinical),Tumor Grade/Stage: cT1c cN0 cM0,-,Yes,White,Not Hispanic or Latino,"Family History: 1st degree relative, Lung cancer; 1st degree relative, Lung cancer; 2nd degree relative, Breast cancer",2021-09-02T00:00:00Z
173,PDXNet Consortium Members,MDACC,TC914,K43540,Female,10025126,Squamous cell lung carcinoma,-,Respiratory/Thoracic,61,43572,Not Reported,TNM (Clinical),Tumor Grade/Stage:  cT1c cN0 cM0,-,Yes,White,Not Hispanic or Latino,"Family Cancer History:  Multiple first-degree relatives with breast cancer (1), lung cancer (1), and one family member with both breast & lung cancer.",2020-08-10T00:00:00Z
174,PDXNet Consortium Members,MDACC,TC920,K88194,Male,10025032,Lung adenocarcinoma,-,Respiratory/Thoracic,72,43528,Not Reported,TNM (Clinical),Tumor Grade/Stage: pT3 pN0 cM0,-,Yes,Not Provided,Not Hispanic or Latino,-,2021-09-02T00:00:00Z
175,PDXNet Consortium Members,MDACC,TC928,K99474,Male,10041071,Small cell lung cancer,-,Respiratory/Thoracic,61,42446,Yes,None Provided,"Location of known metastases: Lung, liver, lymph node, brain",-,No,White,Not Hispanic or Latino,"Family history: 1st degree relatives: Lung adenocarcinoma, Melanoma",2020-12-01T00:00:00Z
176,PDXNet Consortium Members,MDACC,TC936,K19629,Male,10025126,Squamous cell lung carcinoma,-,Respiratory/Thoracic,66,43692,Not Reported,"None Provided, TNM (Clinical), TNM (Pathological)",Tumor Grade/Stage: pT3 pN0 cM0,-,Yes,White,Not Hispanic or Latino,"Family Cancer History:  Two first-degree relatives with cancer, specific details of histology unavailable.",2020-08-10T00:00:00Z
177,PDXNet Consortium Members,MDACC,TC953,K10098,Male,10025032,Lung adenocarcinoma,-,Respiratory/Thoracic,58,43725,Not Reported,TNM,Tumor Stage/Grade: cT3cN0cM0,-,Yes,White,Not Hispanic or Latino,"Family history: 1st Degree Relatives: Breast Ca, Myeloma, Pancreatic Ca (not islets)",2020-12-01T00:00:00Z
178,PDXNet Consortium Members,MDACC,TC974,K43514,Male,10025126,Squamous cell lung carcinoma,-,Respiratory/Thoracic,83,43503,Not Reported,TNM,Tumor Grade/Stage: pT3pN0cM0,"FGFR3-TACC3 (F17T8, COSF1353) fusion",Yes,White,Not Hispanic or Latino,-,2020-12-01T00:00:00Z
179,PDXNet Consortium Members,MDACC,TC978,K38781,Male,10025032,Lung adenocarcinoma,-,Respiratory/Thoracic,76,43917,Not Reported,TNM (Clinical),Tumor Grade/Stage: cT3 cN0 CM0,-,Yes,White,Not Hispanic or Latino,"Family history: 1st Degree Relative, Brain cancer; Undefined relative, Lung adenocarcinoma",2021-09-02T00:00:00Z
180,PDXNet Consortium Members,MDACC,TC979,K55589,Male,10025126,Squamous cell lung carcinoma,-,Respiratory/Thoracic,69,44010,Not Reported,TNM (Clinical),Tumor Grade/Stage: cT3cN0cM0,-,Yes,Not Provided,Not Hispanic or Latino,Prior Diagnoses: Lip and oral cavity squamous cell carcinoma (tongue; Age 65),2021-09-02T00:00:00Z
181,PDXNet Consortium Members,MDACC,TC992,K40289,NA,10025126,Squamous cell lung carcinoma,-,Respiratory/Thoracic,65,43956,Not Reported,TNM (Clinical),Tumor Grade/Stage: cT4cN0cM0,-,No,White,Not Hispanic or Latino,"Family History: 2nd Degree relative, Colon Adenocarcinoma",2021-09-02T00:00:00Z
182,PDXNet Consortium Members,UC Davis,UCD-0006,K39411,Male,10018192,"Urothelial/bladder cancer, NOS",sarcomatoid,Genitourinary,71,43441,Not Reported,None Provided,-,-,Yes,White,Not Provided,"Family History:  1st degree relative with cancer, further details unavailable",2020-10-21T00:00:00Z
183,PDXNet Consortium Members,UC Davis,UCD-0019,K61486,Male,10018192,"Urothelial/bladder cancer, NOS",high grade,Genitourinary,78,43393,Not Reported,TNM (Pathological),Tumor Grade/Stage: pT3bN0Mx,-,No,White,Not Hispanic or Latino,"Concurrent cancer diagnoses: Prostate Cancer (diagnosed 5/2019, Gleason 3+3, pT3aN0Mx)",2020-10-21T00:00:00Z
184,PDXNet Consortium Members,UC Davis,UCD-0025,K10244,Male,10018192,"Urothelial/bladder cancer, NOS",-,Genitourinary,74,43592,Not Reported,Grade,Tumor Grade/Stage: high-grade,-,Not Provided,White,Not Hispanic or Latino,Family History:  1st degree relative with Breast cancer,2020-10-21T00:00:00Z
185,PDXNet Consortium Members,UC Davis,UCD-0030,K11847,Male,10018192,"Urothelial/bladder cancer, NOS",urothelial carcinoma,Genitourinary,76,43480,Not Reported,None Provided,Tumor Grade/Stage: High-grade,-,Yes,White,Not Hispanic or Latino,"Family history: 1st degree relative, Lung Cancer",2021-09-02T00:00:00Z
186,PDXNet Consortium Members,UC Davis,UCD-0042,K92728,Male,10018192,"Urothelial/bladder cancer, NOS","invasive urothelial ca, high grade",Genitourinary,73,43556,Not Reported,TNM,Tumor Grade/Stage: T2,-,No,White,Not Hispanic or Latino,"Concurrent Cancer Diagnosis: Prostatic adenocarcinoma (Gleason score 3+3=6, grade group 1)",2020-10-21T00:00:00Z
187,PDXNet Consortium Members,UC Davis,UCD-0049,K92717,Male,10018192,"Urothelial/bladder cancer, NOS",papillary urothelial,Genitourinary,65,43619,Not Reported,None Provided,Tumor Grade/Stage: High grade,-,No,White,Not Hispanic or Latino,-,2021-09-02T00:00:00Z
188,PDXNet Consortium Members,UC Davis,UCD-0052,K30090,Male,10018192,"Urothelial/bladder cancer, NOS",High grade,Genitourinary,72,43595,Not Reported,TNM (Pathological),Tumor Grade/Stage: pT2b,-,Yes,White,Not Hispanic or Latino,"Family history: 1st degree relative, Mesothelioma",2020-10-21T00:00:00Z
189,PDXNet Consortium Members,UC Davis,UCD-0062,K88526,Male,10018192,"Urothelial/bladder cancer, NOS","urothelial, focal glandular differentiation, 15-20% small cell component",Genitourinary,83,43703,Not Reported,None Provided,Tumor Grade/Stage: High-grade,-,No,White,Not Hispanic or Latino,Patient history: Prostate cancer,2021-09-02T00:00:00Z
190,PDXNet Consortium Members,UC Davis,UCD-0090,K68032,Male,10001150,Adenocarcinoma - stomach,"Invasive and mixed adeno-neuroendocrine carcinoma (MANEC), ulcerated",Digestive/Gastrointestinal,85,43878,Yes,TNM,Tumor Grade/Stage: T1b Location of known metastases: Liver,-,Yes,White,Not Hispanic or Latino,Limited history,2021-09-02T00:00:00Z
191,PDXNet Consortium Members,UC Davis,UCD-0095,K68162,Male,10018192,"Urothelial/bladder cancer, NOS",urothelial ca,Genitourinary,70,43985,Not Reported,TNM (Pathological),"Tumor Grade/Stage: pT3b, high grade",-,Yes,White,Not Hispanic or Latino,"Family history: 1st Degree relative, Stomach Cancer",2021-09-02T00:00:00Z
192,PDXNet Consortium Members,UC Davis,UCLA-0045,K99317,Male,10001150,Adenocarcinoma - stomach,"Poorly differentiated, focal signet ring cell features",Digestive/Gastrointestinal,-,-,Not Reported,None Provided,-,-,Not Provided,Declined to answer,Hispanic or Latino,-,2020-10-21T00:00:00Z
193,PDXNet Consortium Members,UC Davis,UCLA-0048,K99817,Female,10025126,Squamous cell lung carcinoma,"Invasive, moderately to poorly differentiated",Respiratory/Thoracic,-,-,Not Reported,None Provided,-,-,Not Provided,White,Not Hispanic or Latino,-,2020-10-21T00:00:00Z
194,PDXNet Consortium Members,UC Davis,UCLA-0135,K47244,Female,10025126,Squamous cell lung carcinoma,-,Respiratory/Thoracic,-,-,Not Reported,None Provided,-,-,Not Provided,White,Not Hispanic or Latino,Limited medical history,2021-09-02T00:00:00Z
195,PDXNet Consortium Members,UC Davis,UTSW-0001,K28150,Female,10001150,Adenocarcinoma - stomach,gastric adenocarcinoma,Digestive/Gastrointestinal,-,-,Not Reported,None Provided,-,-,Not Provided,White,Hispanic or Latino,-,2021-09-02T00:00:00Z
196,PDXNet Consortium Members,WISTAR,WM4034,K45418,Male,10053571,Melanoma,-,Skin,54,41206,Yes,Stage,Tumor Grade/Stage: Stage IIIC Location of known metastases: Lymph Nodes,BRAF-wild type,Not Provided,Not Provided,Not Provided,-,2019-07-02T00:00:00Z
197,PDXNet Consortium Members,WISTAR,WM4061,K31283,Female,10053571,Melanoma,-,Skin,67,41334,Yes,Stage,Tumor Grade/Stage: Stage IV Location of known metastases: Lymph node,BRAF-V600E,Not Provided,Not Provided,Not Provided,-,2019-07-02T00:00:00Z
198,PDXNet Consortium Members,WISTAR,WM4235,K02933,Female,10053571,Melanoma,Acral,Skin,-,-,Yes,"Stage, TNM",Tumor Grade/Stage: IV-T4bN2bMx Location of known metastasis: Lymph Node (local inguinal) Primary site of disease: Foot/ankle (R),NRAS-Q61R,Not Provided,Not Provided,Not Provided,-,2020-10-20T00:00:00Z
199,PDXNet Consortium Members,WISTAR,WM4251,K19816,Male,10053571,Melanoma,Cutaneous,Skin,-,-,Yes,Stage,"Tumor Grade/Stage: Stage II Location of known metastases: Knee (R, lateral)",NRAS-Q61K,Not Provided,Not Provided,Not Provided,-,2020-10-20T00:00:00Z
200,PDXNet Consortium Members,WISTAR,WM4258-2,K85158,Male,10053571,Melanoma,Non-Acral Cutaneous,Skin,54,41907,Yes,Stage,"Tumor Grade/Stage: Stage IV Location of known metastases: Lung, Axilla (soft tissue and connective tissue)",-,Declined to answer,Not Provided,Not Provided,Limited medical history,2021-09-02T00:00:00Z
201,PDXNet Consortium Members,WISTAR,WM4285,K69516,Male,10053571,Melanoma,Cutaneous,Skin,-,-,Not Reported,None Provided,Tumor Grade/Stage: Grade IV,BRAF-V600E;CKIT-WT;NRAS-WT;EGFR-GERMLINE,Not Provided,Not Provided,Not Provided,-,2020-11-13T00:00:00Z
202,PDXNet Consortium Members,WISTAR,WM4315,K18882,Male,10053571,Melanoma,-,Skin,-,-,Not Reported,None Provided,"Tumor Grade/Stage: Stage IV, M1C",BRAF-V600E,Not Provided,Not Provided,Not Provided,Limited history,2021-09-02T00:00:00Z
203,PDXNet Consortium Members,WISTAR,WM4324,K62034,Male,10053571,Melanoma,Acral Cutaneous,Skin,-,-,Yes,"Stage, TNM","Tumor Grade/Stage: Stage IV, M1c Location of Known Metastases: Left Groin Lymph Nodes, Soft Tissue- Abdomen, Colon, Lung, Pancreas, Mesentary, Skin- Right Shoulder, Liver",BRAF-NA;CKIT-NA;NRAS-WT,Not Provided,Not Provided,Not Provided,-,2020-11-13T00:00:00Z
204,PDXNet Consortium Members,WISTAR,WM4325-2,K50261,Male,10053571,Melanoma,-,Skin,-,-,Yes,Stage,Tumor Grade/Stage: IV Location of known metastasis: lymph nodes,NRAS-WT,Not Provided,Not Provided,Not Provided,-,2019-07-29T00:00:00Z
205,PDXNet Consortium Members,WISTAR,WM4342,K44104,Female,10053571,Melanoma,-,Skin,-,-,Yes,None Provided,Tumor Grade/Stage: Stage IV Location of known metastases: Skin (lower limb/hip),"FGFR2-Q259*, BRAF-wt, CKIT-wt, NF1",Not Provided,Not Provided,Not Provided,-,2021-09-02T00:00:00Z
206,PDXNet Consortium Members,WISTAR,WM4348,K25980,Female,10053571,Melanoma,Uveal,Skin,-,-,Not Reported,None Provided,-,"BRAF Wildtype, GNA11-Q209L",Not Provided,Not Provided,Not Provided,Limited patient history,2021-09-02T00:00:00Z
207,PDXNet Consortium Members,WISTAR,WM4352,K95267,Male,10053571,Melanoma,Non-Acral Cutaneous,Skin,53,41879,Yes,Stage,Tumor Grade/Stage: Stage IV Location of known metastases:  Chest wall,BRAF-V600E;CKIT-WT;NRAS-WT;PIK3CAGERMLINE; TP53-G245S;CDKN2A-P81L;MET-GERMLINE,Not Provided,Not Provided,Not Provided,Limited medical history,2021-09-02T00:00:00Z
208,PDXNet Consortium Members,WISTAR,WM4352-2,K20561,Male,10053571,Melanoma,-,Skin,69,42012,Yes,None Provided,Location of known metastasis: lymph nodes Tumor Grade/Stage: IV,NRAS-WT,Not Provided,Not Provided,Not Provided,-,2019-07-29T00:00:00Z
209,PDXNet Consortium Members,WISTAR,WM4358,K82173,Female,10053571,Melanoma,-,Skin,70,41887,Not Reported,None Provided,Tumor Grade/Stage: Stage III Location of known metastases: Lymph Node,"BRAF-WT, cKIT-WT, NRAS-WT",Not Provided,Not Provided,Not Provided,-,2019-07-02T00:00:00Z
210,PDXNet Consortium Members,WISTAR,WM4365,K75510,Female,10053571,Melanoma,-,Skin,59,41894,Yes,None Provided,Location of known metastases: Lymph node,"BRAF-WT, cKIT-WT, NRAS-WT",Not Provided,Not Provided,Not Provided,-,2019-07-02T00:00:00Z
211,PDXNet Consortium Members,WISTAR,WM4367,K51691,Male,10053571,Melanoma,Non-Acral Cutaneous,Skin,-,-,Not Reported,Stage,Tumor Grade/Stage: Stage III,"BRAF-V600E, CKIT-WT;NRAS-WT, CDKN2A-W110*, PTEN-INDETERMINATE",Not Provided,Not Provided,Not Provided,Limited history,2021-09-02T00:00:00Z
212,PDXNet Consortium Members,WISTAR,WM4369,K18384,Female,10053571,Melanoma,Mucosal,Skin,-,-,Not Reported,None Provided,-,"BRAF-WT, CKIT-WT, NRAS-G13E, NRAS-G13D",Not Provided,Not Provided,Not Provided,Limited history,2021-09-02T00:00:00Z
213,PDXNet Consortium Members,WISTAR,WM4371,K01650,Male,10053571,Melanoma,-,Skin,-,-,Yes,None Provided,"Location of known metastases: Lung, brain",BRAF-V600E,Not Provided,Not Provided,Not Provided,Limited history,2021-09-02T00:00:00Z
214,PDXNet Consortium Members,WISTAR,WM4372,K57782,Female,10053571,Melanoma,Uveal,Skin,-,-,Yes,None Provided,Location of known metastases: Liver,"BRAF Wildtype, GNA11-Q209L",Not Provided,Not Provided,Not Provided,Limited medical information,2021-09-02T00:00:00Z
215,PDXNet Consortium Members,WISTAR,WM4388,K50786,Female,10053571,Melanoma,Non-Acral Cutaneous,Skin,61,41942,Yes,Stage,Tumor Grade/Stage: Stage IV Location of known metastases: Abdomen (soft tissue),"BRAF-V600E, TP53-R213*, CKIT-WT, NRAS-WT",Not Provided,Not Provided,Not Provided,Limited medical history,2021-09-02T00:00:00Z
216,PDXNet Consortium Members,WISTAR,WM4399,K00725,Male,10053571,Melanoma,-,Skin,61,41969,Yes,Stage,Tumor Grade/Stage: Stage IV Location of known metastases: Lung,"BRAF-G469R, KRAS-G12V, CKIT-WT, NRAS-WT",Not Provided,Not Provided,Not Provided,Limited medical history,2021-09-02T00:00:00Z
217,PDXNet Consortium Members,WISTAR,WM4420-3,K63476,Male,10053571,Melanoma,-,Skin,62,41661,Yes,Stage,Tumor Grade/Stage: Stage IV Location of known metastases: Lymph Node,BRAF-V600K,Not Provided,Not Provided,Not Provided,-,2019-07-02T00:00:00Z
218,PDXNet Consortium Members,WISTAR,WM4426,K00430,Female,10053571,Melanoma,Acral cutaneous,Skin,-,-,Not Reported,None Provided,Tumor Grade/Stage: Stage III,RAF-WT;CKIT-WT;NRAS-Q61R,Not Provided,Not Provided,Not Provided,-,2020-11-13T00:00:00Z
219,PDXNet Consortium Members,WISTAR,WM4428,K89678,Male,10053571,Melanoma,-,Skin,-,-,Yes,Stage,Location of known metastases:  lymph nodes Tumor Grade/Stage: IV,BRAF V600E,Not Provided,Not Provided,Not Provided,-,2019-07-29T00:00:00Z
220,PDXNet Consortium Members,WISTAR,WM4435,K40873,Female,10053571,Melanoma,Non-Acral cutaneous,Skin,39,-,Not Reported,None Provided,-,BRAF-V600E,Not Provided,Not Provided,Not Provided,-,2019-05-07T00:00:00Z
221,PDXNet Consortium Members,WISTAR,WM4445,K20921,Female,10053571,Melanoma,-,Skin,55,42075,Yes,Stage,Tumor Grade/Stage: Stage IV Location of known metastases: Abdomen (soft tissue),-,Not Provided,Not Provided,Not Provided,Limited medical history,2021-09-02T00:00:00Z
222,PDXNet Consortium Members,WISTAR,WM4446,K73388,Male,10053571,Melanoma,-,Skin,59,-,Yes,None Provided,Tumor Grade/Stage: Stage IV Location of known metastases: Lymph nodes,BRAF-WT;CKIT-GERMLINE;NRAS-WT;CKDN2a-R58*;TP53-R248W/P152L;MET-GERMLINE;PIK3CA-GERMLINE,Not Provided,Not Provided,Not Provided,-,2019-06-11T00:00:00Z
223,PDXNet Consortium Members,WISTAR,WM4454,K39077,Male,10053571,Melanoma,-,Skin,59,-,Yes,Stage,Tumor Grade/Stage: Stage IV Location of known metastases: Lymph nodes,BRAF-V600E;CKIT-WT;NRAS-WT;TP53-C275W;PIK3CA-GERMLINE,Not Provided,Not Provided,Not Provided,-,2019-06-11T00:00:00Z
224,PDXNet Consortium Members,WISTAR,WM4455,K63542,Male,10053571,Melanoma,-,Skin,62,42090,Yes,Stage,Tumor Grade/Stage: IV Location of known metastases: lymph nodes,NF1 mutant,Not Provided,Not Provided,Not Provided,-,2019-07-03T00:00:00Z
225,PDXNet Consortium Members,WISTAR,WM4457,K38709,Female,10053571,Melanoma,Non-acral skin,Skin,-,-,Yes,Stage,"Tumor Grade/Stage: Stage IV Location of known metastases: Back/axilla (R), Lung Primary site of disease: Scapula, skin",BRAF-V600E,Not Provided,Not Provided,Not Provided,Limited medical information,2021-09-02T00:00:00Z
226,PDXNet Consortium Members,WISTAR,WM4458,K05832,Male,10053571,Melanoma,-,Skin,61,-,Not Reported,None Provided,-,FGFR3 amplification,Not Provided,Not Provided,Not Provided,-,2019-05-07T00:00:00Z
227,PDXNet Consortium Members,WISTAR,WM4459-2,K97757,Female,10053571,Melanoma,-,Skin,-,-,Yes,None Provided,Location of known metastases: Lymph node,BRAF-V600E,Not Provided,Not Provided,Not Provided,-,2019-04-25T00:00:00Z
228,PDXNet Consortium Members,WISTAR,WM4460,K73281,Male,10053571,Melanoma,Uveal,Skin,-,-,Yes,Stage,Tumor Grade/Stage: IV Location of known metastases: Liver,"BRAF Wildtype, GNA11-Q209L",Not Provided,Not Provided,Not Provided,Limited patient information,2021-09-02T00:00:00Z
229,PDXNet Consortium Members,WISTAR,WM4465-2,K59086,Male,10053571,Melanoma,-,Skin,-,-,Yes,Stage,"Known Location of Metastasis:  lymph nodes Tumor Grade/Stage: IV, M1C",BRAF V600K,Not Provided,Not Provided,Not Provided,-,2019-07-29T00:00:00Z
230,PDXNet Consortium Members,WISTAR,WM4466,K00012,Female,10053571,Melanoma,Non-Acral Cutaneous,Skin,-,-,Yes,"Stage, TNM","Tumor Grade/Stage: Stage IV, M1A Location of known metastases: Lymph node (inguinal)",BRAF-V600E;NRAS-WT;CKIT-WT,Not Provided,Not Provided,Not Provided,Limited history available,2021-09-02T00:00:00Z
231,PDXNet Consortium Members,WISTAR,WM4467,K18800,Female,10053571,Melanoma,-,Skin,50,39083,Yes,Stage,Tumor Grade/Stage: IV Location of known metastases: lymph nodes,BRAF WT,Not Provided,Not Provided,Not Provided,-,2019-07-03T00:00:00Z
232,PDXNet Consortium Members,WISTAR,WM4468-2,K29715,Female,10053571,Melanoma,Cutaneous,Skin,-,-,Yes,"Stage, TNM","Tumor Grade/Stage: Stage IV, M1A Location of known metastases: Back NOS",BRAF-V600E;NRAS-WT;CKIT-WT,Not Provided,Not Provided,Not Provided,-,2020-10-20T00:00:00Z
233,PDXNet Consortium Members,WISTAR,WM4470,K37318,Female,10053571,Melanoma,-,Skin,-,-,Yes,None Provided,Tumor Grade/Stage: Stage IV M1C Location of known metastases: not reported,BRAF wild type,Not Provided,Not Provided,Not Provided,-,2019-04-25T00:00:00Z
234,PDXNet Consortium Members,WISTAR,WM4472,K46655,Male,10053571,Melanoma,-,Skin,67,-,Not Reported,Stage,Tumor Grade/Stage: Stage IIIC,BRAF-V600E,Not Provided,Not Provided,Not Provided,-,2019-05-07T00:00:00Z
235,PDXNet Consortium Members,WISTAR,WM4473,K97705,Male,10053571,Melanoma,-,Skin,48,-,Yes,None Provided,Location of Known Metastasis: lymph nodes,-,Not Provided,Not Provided,Not Provided,-,2019-07-30T00:00:00Z
236,PDXNet Consortium Members,WISTAR,WM4474,K02076,Male,10053571,Melanoma,-,Skin,73,-,Not Reported,Stage,Tumor Grade/Stage: Stage IV,BRAF-V600E,Not Provided,Not Provided,Not Provided,-,2019-05-07T00:00:00Z
237,PDXNet Consortium Members,WISTAR,WM4481-1,K50841,Male,10053571,Melanoma,Uveal,Skin,-,-,Yes,Stage,Tumor Grade/Stage: IV M1C Location of known metastases: Axilla NOS,-,Not Provided,Not Provided,Not Provided,Limited medical history,2021-09-02T00:00:00Z
238,PDXNet Consortium Members,WISTAR,WM4484,K45485,Male,10053571,Melanoma,-,Skin,53,39083,Yes,Stage,Tumor Grade/Stage:  IV Location of known metastases: lymph nodes,NRAS Q61R,Not Provided,Not Provided,Not Provided,-,2019-07-03T00:00:00Z
239,PDXNet Consortium Members,WISTAR,WM4485,K70470,Male,10053571,Melanoma,-,Skin,64,-,Not Reported,None Provided,-,-,Not Provided,Not Provided,Not Provided,-,2019-05-07T00:00:00Z
240,PDXNet Consortium Members,WISTAR,WM4492,K06728,Male,10053571,Melanoma,-,Skin,-,-,Yes,Stage,Tumor Grade/Stage: Stage M1a Location of known metastases: Thigh (L),BRAF-V600E,Not Provided,Not Provided,Not Provided,-,2019-04-25T00:00:00Z
241,PDXNet Consortium Members,WISTAR,WM4495,K96150,Female,10053571,Melanoma,-,Skin,-,-,Yes,Stage,Location of known metastasis: lymph nodes Tumor Grade/Stage:  M1a,NRAS Q61K mutation,Not Provided,Not Provided,Not Provided,-,2019-07-29T00:00:00Z
242,PDXNet Consortium Members,WISTAR,WM4499,K73791,Female,10053571,Melanoma,-,Skin,-,-,Yes,None Provided,"Location of known metastasis: Axilla (R), Lymph nodes Tumor Grade/Stage: Stage IIc",BRAF wild type,Not Provided,Not Provided,Not Provided,-,2019-04-25T00:00:00Z
243,PDXNet Consortium Members,WISTAR,WM4502,K83886,Female,10053571,Melanoma,-,Skin,-,-,Yes,Stage,Tumor Grade/Stage: IIIC,BRAF V600E; PIK3CA H1047L mutation,Not Provided,Not Provided,Not Provided,-,2019-07-30T00:00:00Z
244,PDXNet Consortium Members,WISTAR,WM4503,K73560,Female,10053571,Melanoma,-,Skin,-,-,Yes,"Stage, TNM","Tumor Grade/Stage: Stage III, TxN1M0 Location of known metastases: Neck (L)",BRAF-positive,Not Provided,Not Provided,Not Provided,-,2020-10-20T00:00:00Z
245,PDXNet Consortium Members,WISTAR,WM4504,K86949,Female,10053571,Melanoma,Cutaneous,Skin,-,-,Yes,Stage,"Tumor Grade/Stage: Stage IV, M1A Location of known metastases: Breast","BRCA2-Q3295*, RB1-L335*, NRAS-Q61L, BRAF-wt, CKIT-wt",Not Provided,Not Provided,Not Provided,-,2021-09-02T00:00:00Z
246,PDXNet Consortium Members,WISTAR,WM4505-3,K63500,Male,10053571,Melanoma,-,Skin,20,41913,Yes,Stage,Tumor Grade/Stage: IV Location of known metastases: lymph nodes,BRAF V600E,Not Provided,Not Provided,Not Provided,-,2019-07-03T00:00:00Z
247,PDXNet Consortium Members,WISTAR,WM4509,K85278,Male,10053571,Melanoma,-,Skin,-,-,Not Reported,None Provided,"Tumor Grade/Stage: Stage IV, cM1",BRAF-V600E;NRAS-WT;CKIT-WT,Not Provided,Not Provided,Not Provided,-,2020-11-13T00:00:00Z
248,PDXNet Consortium Members,WISTAR,WM4513,K12129,Female,10053571,Melanoma,-,Skin,45,42202,Yes,Stage,Tumor Grade/Stage:  III Location of known metastases: lymph nodes,BRAF V600E,Not Provided,Not Provided,Not Provided,-,2019-07-03T00:00:00Z
249,PDXNet Consortium Members,WISTAR,WM4519,K68502,Male,10053571,Melanoma,-,Skin,73,-,Yes,Stage,Tumor Grade/Stage: Stage IV Location of known metastases: Lymph nodes,BRAF V600E and PTEN mutations,Not Provided,Not Provided,Not Provided,-,2019-06-11T00:00:00Z
250,PDXNet Consortium Members,WISTAR,WM4525,K95338,Male,10053571,Melanoma,-,Skin,53,-,Yes,None Provided,Tumor Grade/Stage: Stage IV Location of known metastases: Lymph nodes,BRAF-V600E;NRAS-WT;CKIT-WT,Not Provided,Not Provided,Not Provided,-,2019-06-11T00:00:00Z
251,PDXNet Consortium Members,WISTAR,WM4563,K83112,Female,10053571,Melanoma,-,Skin,-,-,Yes,Stage,Location of known metastasis: lymph nodes Tumor Grade/Stage: IV M1a,BRAF WT; no clinical SNVs,Not Provided,Not Provided,Not Provided,-,2019-07-30T00:00:00Z
252,PDXNet Consortium Members,WISTAR,WM4601-1,K43719,NA,10053571,Melanoma,-,Skin,-,-,Yes,None Provided,Location of known metastases: Lymph nodes,-,Not Provided,Not Provided,Not Provided,-,2019-06-11T00:00:00Z
253,PDXNet Consortium Members,WISTAR,WM4614-2,K42112,NA,10053571,Melanoma,-,Skin,-,-,Yes,None Provided,Location of known metastasis: lymph nodes,-,Not Provided,Not Provided,Not Provided,-,2019-07-30T00:00:00Z
254,PDXNet Consortium Members,WISTAR,WM4616,K84241,NA,10053571,Melanoma,-,Skin,-,-,Yes,Stage,Location of known metastasis:  lymph nodes Tumor Grade/Stage:  IIIB,-,Not Provided,Not Provided,Not Provided,-,2019-07-30T00:00:00Z
255,PDXNet Consortium Members,WISTAR,WM4620,K38533,Male,10053571,Melanoma,Cutaneous,Skin,-,-,Not Reported,Stage,Tumor Grade/Stage: Stage IIC,-,Not Provided,White,Not Hispanic or Latino,-,2021-09-02T00:00:00Z
256,PDXNet Consortium Members,WISTAR,WM4621,K70901,Male,10053571,Melanoma,-,Skin,-,-,Yes,Stage,Tumor Grade/Stage: Stage III Location of known metastases: Axillary Lymph node (R),BRAF p.L597S c.1789_1790delinsTC ; CTNNB1 p.S37C c.110C>G ; DNMT3A p.R882H c.2645G>A ; NF1 p.Y628Lfs*6 c.1882dupT ; NF1 p.R2517* c.7549C>T ; CDKN2A p.W15* c.44G>A ; SETD2 p.E399_R400delinsD* c.1197_1198delinsTT,Not Provided,Not Provided,Not Provided,-,2019-04-25T00:00:00Z
257,PDXNet Consortium Members,WISTAR,WM4628-1,K01852,NA,10007423,"Carcinoma, NOS",-,Unknown Primary,-,-,Not Reported,None Provided,No patient history or diagnosis information,-,Not Provided,Not Provided,Not Provided,-,2020-10-20T00:00:00Z
258,PDXNet Consortium Members,WISTAR,WM4640,K94970,Male,10053571,Melanoma,-,Skin,74,-,Yes,Stage,Tumor Grade/Stage: Stage IIID Location of known metastases: Lymph node,BRAF V600K (c.1798_1799GT>AA),Not Provided,Not Provided,Not Provided,-,2020-11-13T00:00:00Z
259,PDXNet Consortium Members,WUSTL,WU-0001-T1,K59428,Male,10052747,Adenocarcinoma - pancreas,invasive ductal adenocarcinoma,Digestive/Gastrointestinal,71,-,Not Reported,TNM,"Tumor Grade/Stage: T3N1MX, moderately to poorly differentiated",-,Not Provided,White,Not Hispanic or Latino,-,2019-02-21T00:00:00Z
260,PDXNet Consortium Members,WUSTL,WU-0002-T1,K01474,Male,10052747,Adenocarcinoma - pancreas,adenocarcinoma,Digestive/Gastrointestinal,72,-,Not Reported,TNM (Pathological),"Tumor Grade/Stage: pT3N1MX, poorly differentiated",-,Not Provided,White,Not Hispanic or Latino,-,2019-02-21T00:00:00Z
261,PDXNet Consortium Members,WUSTL,WU-0003-T1,K74272,Male,10052747,Adenocarcinoma - pancreas,adenocarcinoma,Digestive/Gastrointestinal,66,-,Yes,TNM,"Tumor Grade/Stage: TxNxM1, moderate to poorly differentiated  Location of known metastases: Abdominal wall",-,Not Provided,White,Not Hispanic or Latino,-,2019-02-21T00:00:00Z
262,PDXNet Consortium Members,WUSTL,WU-0004-T1,K26234,Male,10052747,Adenocarcinoma - pancreas,invasive ductal adenocarcinoma,Digestive/Gastrointestinal,76,-,Not Reported,"Stage, TNM","Tumor Grade/Stage: T1N2MX, Stage 3. poorly differentiated",-,Not Provided,White,Not Hispanic or Latino,-,2019-02-21T00:00:00Z
263,PDXNet Consortium Members,WUSTL,WU-0005-T1,K60898,Female,10052747,Adenocarcinoma - pancreas,-,Digestive/Gastrointestinal,74,-,Not Reported,"Stage, TNM","Tumor Grade/Stage: T2N0MX, Stage Ib, Moderately differentiated","IHC: P40+, CK5/6+, CK7+, TTF1-, CK20-",Not Provided,Black or African American,Not Hispanic or Latino,CDX2+ adenocarcinoma and CDX2- squamoid areas noted by pathology,2019-02-21T00:00:00Z
264,PDXNet Consortium Members,WUSTL,WU-0006-T1,K30141,Male,10052747,Adenocarcinoma - pancreas,"invasive, ductal",Digestive/Gastrointestinal,72,-,Yes,TNM,"Tumor Grade/Stage: T3N1M1, poorly differentiated Location of known metastases: Peritoneum",-,Not Provided,Not Provided,Not Provided,-,2019-02-27T00:00:00Z
265,PDXNet Consortium Members,WUSTL,WU-0007-T1,K48872,Male,10052747,Adenocarcinoma - pancreas,-,Digestive/Gastrointestinal,67,-,Not Reported,TNM,"Tumor Grade/Stage: T3N1MX, poorly differentiated",-,Not Provided,Not Provided,Not Provided,-,2019-03-12T00:00:00Z
266,PDXNet Consortium Members,WUSTL,WU-0008-T1,K02644,Male,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,71,-,Yes,"Stage, TNM","Tumor Grade/Stage: T3N2M1, Stage 4 Location of known metastases: Liver",-,Not Provided,White,Not Hispanic or Latino,-,2019-02-26T00:00:00Z
267,PDXNet Consortium Members,WUSTL,WU-0009-T1,K21501,Male,10052747,Adenocarcinoma - pancreas,invasive ductal,Digestive/Gastrointestinal,72,-,Not Reported,TNM,"Tumor Grade/Stage: T3N1MX, Poorly differentiated",-,Not Provided,White,Not Hispanic or Latino,-,2019-02-26T00:00:00Z
268,PDXNet Consortium Members,WUSTL,WU-0010-T1 (001-R1),K20605,Male,10038045,Adenocarcinoma - rectum,-,Digestive/Gastrointestinal,60,-,Yes,TNM,"Tumor Grade/Stage: T3N1bM1b, moderately differentiated Location of known metastases: Liver",-,Not Provided,White,Not Hispanic or Latino,-,2019-02-26T00:00:00Z
269,PDXNet Consortium Members,WUSTL,WU-0010-T2 (001-R2),K20605,Male,10038045,Adenocarcinoma - rectum,-,Digestive/Gastrointestinal,60,-,Yes,TNM,"Tumor Grade/Stage: T3N1bM1b, moderately differentiated Location of known metastases: Liver",-,Not Provided,White,Not Hispanic or Latino,-,2019-02-26T00:00:00Z
270,PDXNet Consortium Members,WUSTL,WU-0011-T1,K12645,Male,10052747,Adenocarcinoma - pancreas,invasive,Digestive/Gastrointestinal,55,-,Not Reported,None Provided,"Tumor Grade/Stage: T2N1MX, poorly differentiated",-,Not Provided,Not Provided,Not Provided,-,2019-02-26T00:00:00Z
271,PDXNet Consortium Members,WUSTL,WU-0012-T1,K51059,Female,10052747,Adenocarcinoma - pancreas,invasive,Digestive/Gastrointestinal,70,-,Not Reported,None Provided,"Tumor Grade/Stage: T3N1MX, moderately differentiated",-,Not Provided,Not Provided,Not Provided,-,2019-02-27T00:00:00Z
272,PDXNet Consortium Members,WUSTL,WU-0013-T1,K93327,Male,10052747,Adenocarcinoma - pancreas,invasive,Digestive/Gastrointestinal,61,-,Not Reported,TNM,"Tumor Grade/Stage: T3N0M0, poorly differentiated",-,Not Provided,Not Provided,Not Provided,-,2019-02-27T00:00:00Z
273,PDXNet Consortium Members,WUSTL,WU-0014-T1,K30275,Male,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,60,-,Yes,None Provided,Location of known metastases: Liver,"K-RAS mutated, BRAF non-mutated, PIK3CA wild-type, MSI-Stable",Not Provided,Not Provided,Not Provided,-,2019-02-27T00:00:00Z
274,PDXNet Consortium Members,WUSTL,WU-0015-T1,K74678,Male,10009951,Adenocarcinoma - colon,Enteric sub-type,Digestive/Gastrointestinal,42,-,Yes,TNM (Pathological),Tumor Grade/Stage:ypT3N1cM1b Location of known metastases: Liver,"K-RAS mutated, BRAF non-mutated, PIK3CA wild-type, MSI-Stable",Not Provided,Not Provided,Not Provided,-,2019-02-27T00:00:00Z
275,PDXNet Consortium Members,WUSTL,WU-0016-T1,K56145,Male,10052747,Adenocarcinoma - pancreas,-,Digestive/Gastrointestinal,62,-,Not Reported,TNM,"Tumor Grade/Stage: pT3N1MX, Moderate to poorly differentiated","KRAS p.G12D, RET - p.L56M RET - p.P1047S",Not Provided,Not Provided,Not Provided,-,2019-03-12T00:00:00Z
276,PDXNet Consortium Members,WUSTL,WU-0017-T1,K52754,Male,10052747,Adenocarcinoma - pancreas,ductal adenocarcinoma with neuroendocrine features,Digestive/Gastrointestinal,50,-,Not Reported,TNM,Tumor Stage/Grade: ypT3N1MX,-,Not Provided,Not Provided,Not Provided,-,2019-03-12T00:00:00Z
277,PDXNet Consortium Members,WUSTL,WU-0018-T1,K14050,Male,10052747,Adenocarcinoma - pancreas,ductal adenocarcinoma,Digestive/Gastrointestinal,78,-,Not Reported,TNM,Tumor Grade/Stage: pT3N1Mx,BRCA2 mutated,Not Provided,Not Provided,Not Provided,-,2019-03-12T00:00:00Z
278,PDXNet Consortium Members,WUSTL,WU-0019-T1,K33604,Male,10009951,Adenocarcinoma - colon,adenocarcinoma,Digestive/Gastrointestinal,71,-,Yes,"Stage, TNM","Tumor Grade/Stage: Stage III, T3N1, moderately differentiated Location of known metastases: Liver",-,Not Provided,Not Provided,Not Provided,-,2019-03-12T00:00:00Z
279,PDXNet Consortium Members,WUSTL,WU-0020-T1,K32783,Male,10053571,Melanoma,Cutaneous melanoma,Skin,44,-,Yes,Stage,Tumor Grade/Stage: Stage IIIC Location of known metastasis: Buttock,BRAF wild type (IHC),Not Provided,Not Provided,Not Provided,-,2019-03-13T00:00:00Z
280,PDXNet Consortium Members,WUSTL,WU-0021-T1 (001-R1),K21101,Female,10009951,Adenocarcinoma - colon,Enteric type,Digestive/Gastrointestinal,43,-,Not Reported,TNM,Tumor Grade/Stage: pT3N1M1a Location of known metastasis: Liver,"MSI-Stable (IHC); Seq: PI3KCA(H1047R), ERBB2(G776V), ERBB3(E923G), KRAS/NRAS/BRAF(wild-type)",Not Provided,Not Provided,Not Provided,"Based on second liver biopsy: concurrent rectal adenocarcinoma (MSI-High, PIK3CA mutated, DLL3+)",2019-03-13T00:00:00Z
281,PDXNet Consortium Members,WUSTL,WU-0021-T2 (001-R2),K21101,Female,10009951,Adenocarcinoma - colon,Enteric type,Digestive/Gastrointestinal,43,-,Not Reported,TNM,Tumor Grade/Stage: pT3N1M1a Location of known metastasis: Liver,"MSI-Stable (IHC); Seq: PI3KCA(H1047R), ERBB2(G776V), ERBB3(E923G), KRAS/NRAS/BRAF(wild-type)",Not Provided,Not Provided,Not Provided,"Based on second liver biopsy: concurrent rectal adenocarcinoma (MSI-High, PIK3CA mutated, DLL3+)",2019-03-13T00:00:00Z
282,PDXNet Consortium Members,WUSTL,WU-0022-T1,K09796,Female,10052747,Adenocarcinoma - pancreas,-,Digestive/Gastrointestinal,47,-,Not Reported,None Provided,-,-,Not Provided,Not Provided,Not Provided,-,2019-03-13T00:00:00Z
283,PDXNet Consortium Members,WUSTL,WU-0023-T1,K55373,Male,10052747,Adenocarcinoma - pancreas,mucinous and focal signet ring features,Digestive/Gastrointestinal,69,-,Not Reported,"Stage, TNM","Tumor Grade/Stage: T3N0M0, Stage IIA, Moderately differentiated",-,Not Provided,Not Provided,Not Provided,-,2019-03-13T00:00:00Z
284,PDXNet Consortium Members,WUSTL,WU-0024-T1,K63724,Female,10010029,"Colorectal cancer, NOS",-,Digestive/Gastrointestinal,73,-,Yes,TNM,Tumor Grade/Stage: T4bN2bM1a Location of known metastasis: Liver,-,Not Provided,Not Provided,Not Provided,-,2019-03-14T00:00:00Z
285,PDXNet Consortium Members,WUSTL,WU-0025-T1,K49189,Male,10017986,"Gastrointestinal cancer, NOS",adenocarcinoma of the duodenum,Digestive/Gastrointestinal,52,-,Yes,None Provided,Location of known metastasis: Peritoneum Tumor Stage/Grade: Poorly differentiated,-,Not Provided,Not Provided,Not Provided,-,2019-03-14T00:00:00Z
286,PDXNet Consortium Members,WUSTL,WU-0026-T1,K62367,Male,10052747,Adenocarcinoma - pancreas,Adenosquamous carcinoma,Digestive/Gastrointestinal,48,-,Yes,"Stage, TNM","Tumor Grade/Stage: Stage 4, TxNxM1 Location of known metastasis: Liver","KRAS-G12D, p16INK4a-D153N, and mutations in CDKN2A and MYST3",Not Provided,Not Provided,Not Provided,-,2019-03-14T00:00:00Z
287,PDXNet Consortium Members,WUSTL,WU-0027-T1,K01212,Female,10009951,Adenocarcinoma - colon,Invasive mucinous and signet ring cell features,Digestive/Gastrointestinal,74,-,Yes,TNM,"Tumor Grade/Stage: pT3pN2a, poorly differentiated Location of known metastasis: Liver",-,Not Provided,Not Provided,Not Provided,-,2019-03-14T00:00:00Z
288,PDXNet Consortium Members,WUSTL,WU-0028-T1,K59530,Female,10019810,Liver/hepatobiliary cancer,Intrahepatic cholangiocarcinoma,Digestive/Gastrointestinal,62,-,Yes,TNM,"Tumor Grade/Stage: TxNxM1, Poorly differentiated Location of known metastasis: Peritoneum, Liver","KRAS-G122D, CDKN2A loss, Dicer1-R944*,  Notch2 Duplication (exons 3-13)",Not Provided,Not Provided,Not Provided,-,2019-03-14T00:00:00Z
289,PDXNet Consortium Members,WUSTL,WU-0029-T1,K64457,Male,10018192,"Urothelial/bladder cancer, NOS",invasive,Genitourinary,75,-,Yes,TNM,"Tumor Grade/Stage: TxN1M0, high grade Location of known metastases: Lymph node",-,Not Provided,Not Provided,Not Provided,-,2019-04-16T00:00:00Z
290,PDXNet Consortium Members,WUSTL,WU-0030-T1,K07094,Female,10018192,"Urothelial/bladder cancer, NOS",invasive,Genitourinary,49,-,Yes,None Provided,"Tumor Grade/Stage: ypT4aNXMX, High grade Location of known metastases: Lymph node, bone, liver, skin",-,Not Provided,Not Provided,Not Provided,-,2019-04-16T00:00:00Z
291,PDXNet Consortium Members,WUSTL,WU-0031-T1,K89416,Male,10060121,"H & N squamous cell car., NOS",-,Head and Neck,70,-,Yes,None Provided,"Location of known metastases: Liver, Lymph node",-,Not Provided,Not Provided,Not Provided,-,2019-04-16T00:00:00Z
292,PDXNet Consortium Members,WUSTL,WU-0032-T1,K27677,Female,10025126,Squamous cell lung carcinoma,-,Respiratory/Thoracic,59,-,Yes,TNM,"Tumor Grade/Stage: T3N0M0 Location of known metastases: Thorax, kidney",-,Not Provided,Not Provided,Not Provided,-,2019-04-16T00:00:00Z
293,PDXNet Consortium Members,WUSTL,WU-0033-T1,K40368,Female,10006190,Invasive breast carcinoma,-,Breast,42,-,Yes,None Provided,"Tumor Grade/Stage: T1N0M0 Location of known metastases: Liver, Lung","ER+, PR+, Her2-",Not Provided,Not Provided,Not Provided,-,2019-04-16T00:00:00Z
294,PDXNet Consortium Members,WUSTL,WU-0034-T1,K79373,Male,10044409,Transitional cell car. - uroth.,"invasive, high grade",Genitourinary,64,-,Yes,None Provided,Location of known metastases: Lung,-,Not Provided,Not Provided,Not Provided,-,2019-04-17T00:00:00Z
295,PDXNet Consortium Members,WUSTL,WU-0035-T1,K10183,Female,10017986,"Gastrointestinal cancer, NOS",-,Digestive/Gastrointestinal,69,-,Not Reported,None Provided,"Location of known metastases: Brain, Lung, Abdominal Wall",-,Not Provided,Not Provided,Not Provided,-,2019-04-17T00:00:00Z
296,PDXNet Consortium Members,WUSTL,WU-0036-T1,K56855,Male,10009251,"RCC, clear cell adenocarcinoma",-,Genitourinary,58,-,Yes,None Provided,Tumor Grade/Stage: pT3aNxMx Location of known metastases: Lung (RML),"Mutations reported in: VHL, CDKN2A",Not Provided,Not Provided,Not Provided,-,2019-04-17T00:00:00Z
297,PDXNet Consortium Members,WUSTL,WU-0037-T1,K77151,Male,10009251,"RCC, clear cell adenocarcinoma",-,Genitourinary,63,-,Yes,TNM,"Tumor Grade/Stage: pT3aNo Location of known metastases: brain, lung","Mutations reported in: VHL, PBRM1, PTEN, ARID1A",Not Provided,Not Provided,Not Provided,-,2019-04-17T00:00:00Z
298,PDXNet Consortium Members,WUSTL,WU-0038-T2,K08381,Male,10026667,Malig. periph. nerve sheath tum.,-,Musculoskeletal,39,-,Yes,"Stage, TNM","Tumor Grade/Stage: T2N0M1, Stage IV Location of known metastases: Lung, humerus, vertebra",-,Not Provided,Not Provided,Not Provided,-,2019-04-17T00:00:00Z
299,PDXNet Consortium Members,WUSTL,WU-0039-T1,K90731,Male,10039494,Non-Rhabdo. soft tissue sarcoma,"Spindle cell, biphenotypic",Musculoskeletal,25,-,Not Reported,TNM,"Tumor Grade/Stage: T1N0M0, High grade",-,Not Provided,Not Provided,Not Provided,-,2019-04-18T00:00:00Z
300,PDXNet Consortium Members,WUSTL,WU-0040-T1,K84253,Female,10006190,Invasive breast carcinoma,ductal,Breast,55,-,Yes,None Provided,"Tumor Grade/Stage: High grade Location of known metastases: Bone, brain, lung","ER+, HER2-",Not Provided,Not Provided,Not Provided,-,2019-04-18T00:00:00Z
301,PDXNet Consortium Members,WUSTL,WU-0041-T1,K12492,Male,10034819,Pharyngeal squam. cell carcinoma,Oropharynx,Head and Neck,57,-,Yes,TNM,Tumor Grade/Stage: T2N1M0 Location of known metastases: Lymph node,p16+,Not Provided,Not Provided,Not Provided,-,2019-04-18T00:00:00Z
302,PDXNet Consortium Members,WUSTL,WU-0042-T1,K47837,Female,10026667,Malig. periph. nerve sheath tum.,-,Musculoskeletal,36,-,Yes,None Provided,Location of known metastases: Bone,-,Not Provided,Not Provided,Not Provided,-,2019-04-18T00:00:00Z
303,PDXNet Consortium Members,WUSTL,WU-0043-T1,K64145,Female,10039494,Non-Rhabdo. soft tissue sarcoma,-,Musculoskeletal,90,-,Not Reported,"Stage, TNM","Tumor Grade/Stage: T2bN0Mx, Stage IV, High-grade",-,Not Provided,Not Provided,Not Provided,-,2019-04-18T00:00:00Z
304,PDXNet Consortium Members,WUSTL,WU-0044-T1,K48732,Female,10017986,"Gastrointestinal cancer, NOS",Extra-gastrointestinal stromal tumor (EGIST) of the pancreas.,Digestive/Gastrointestinal,82,-,Not Reported,"Stage, TNM","Tumor Grade/Stage: Stage 1b, pT2N0MX, Moderately differentiated Primary site: pancreas",-,Not Provided,Not Provided,Not Provided,-,2019-05-14T00:00:00Z
305,PDXNet Consortium Members,WUSTL,WU-0045-T1 (R1),K01349,Male,10009951,Adenocarcinoma - colon,"Sigmoid colon ca, Invasive",Digestive/Gastrointestinal,34,-,Yes,"Stage, TNM","Tumor Grade/Stage: Stage IVA, TXNXM1a, moderately differentiated Location of known metastases: Liver",-,Not Provided,Not Provided,Not Provided,-,2019-05-14T00:00:00Z
306,PDXNet Consortium Members,WUSTL,WU-0045-T2 (R2),K01349,Male,10009951,Adenocarcinoma - colon,"Sigmoid colon ca, Invasive",Digestive/Gastrointestinal,34,-,Yes,"Stage, TNM","Tumor Grade/Stage: Stage IVA, TXNXM1a, moderately differentiated Location of known metastases: Liver",-,Not Provided,Not Provided,Not Provided,-,2019-05-14T00:00:00Z
307,PDXNet Consortium Members,WUSTL,WU-0046-T1,K40660,Female,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,50,-,Yes,TNM,"Tumor Grade/Stage: T4aN1M1, moderately differentiated Location of known metastases: Liver",-,Not Provided,Not Provided,Not Provided,-,2019-05-14T00:00:00Z
308,PDXNet Consortium Members,WUSTL,WU-0047-T1 (R1),K55642,Female,10038045,Adenocarcinoma - rectum,-,Digestive/Gastrointestinal,71,-,Yes,Stage,Tumor Grade/Stage: T3N0M0 Location of known metastases: Liver,-,Not Provided,Not Provided,Not Provided,-,2019-05-15T00:00:00Z
309,PDXNet Consortium Members,WUSTL,WU-0047-T2 (R2),K55642,Female,10038045,Adenocarcinoma - rectum,-,Digestive/Gastrointestinal,71,-,Yes,Stage,Tumor Grade/Stage: T3N0M0 Location of known metastases: Liver,-,Not Provided,Not Provided,Not Provided,-,2019-05-15T00:00:00Z
310,PDXNet Consortium Members,WUSTL,WU-0048-T1,K53585,Male,10052747,Adenocarcinoma - pancreas,"Pancreatobiliary tumor, Adenosquamous carcinoma",Digestive/Gastrointestinal,66,-,Yes,"Stage, TNM","Tumor Grade/Stage: Stage IV, T3N1M0 Location of known metastases: Scalp, Skin, Bone, Hip, Lung Primary: Pancreatobilliary",-,Not Provided,Not Provided,Not Provided,-,2019-05-14T00:00:00Z
311,PDXNet Consortium Members,WUSTL,WU-0060-T1,K62287,Male,10052747,Adenocarcinoma - pancreas,ductal adenocarcinoma,Digestive/Gastrointestinal,67,-,Not Reported,TNM,"Tumor Grade/Stage: T2N1M0, Poorly differentiated",-,Not Provided,Not Provided,Not Provided,-,2019-05-15T00:00:00Z
312,PDXNet Consortium Members,WUSTL,WU-0061-T1,K39738,Male,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,59,-,Yes,Stage,"Tumor Grade/Stage: Stage IV, moderately differentiated Location of known metastases: Liver",-,Not Provided,Not Provided,Not Provided,-,2019-05-15T00:00:00Z
313,PDXNet Consortium Members,WUSTL,WU-0062-T1,K35237,Female,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,68,-,Yes,None Provided,Location of known metastases: Liver,"Primary tumor: CDX2+, CK20 (focally positive), SATB2-, CK7-",Not Provided,Not Provided,Not Provided,-,2019-05-15T00:00:00Z
314,PDXNet Consortium Members,WUSTL,WU-0063-T1,K85033,Female,10052747,Adenocarcinoma - pancreas,"Adenosquamous carcinoma, gastric foveolar type IPMN",Digestive/Gastrointestinal,72,-,Not Reported,None Provided,Tumor Grade/Stage: T3N2M0,-,Not Provided,Not Provided,Not Provided,-,2019-05-16T00:00:00Z
315,PDXNet Consortium Members,WUSTL,WU-0066-T1,K95336,Female,10052747,Adenocarcinoma - pancreas,pancreatic ductal adenocarcinoma,Digestive/Gastrointestinal,79,-,Not Reported,TNM,"Tumor Grade/Stage: T3N1M0, moderately to poorly-differentiated","DNA mismatch repair (MMR) enzymes MLH1, MSH2, MSH6, and PMS2 have been retained (IHC)",Not Provided,Not Provided,Not Provided,-,2019-05-16T00:00:00Z
316,PDXNet Consortium Members,WUSTL,WU-0067-T1,K95696,Male,10009951,Adenocarcinoma - colon,-,Digestive/Gastrointestinal,71,-,Not Reported,"Stage, TNM","Tumor Grade/Stage: Stage IIA, T3N0M0, Low-grade (well-differentiated to moderately differentiated)","DNA mismatch repair (MMR) enzymes MLH1, MSH2, MSH6, and PMS2 have been retained (IHC)",Not Provided,Not Provided,Not Provided,-,2019-05-16T00:00:00Z
317,PDXNet Consortium Members,WUSTL,WU-0068-T1,K89392,Male,10052747,Adenocarcinoma - pancreas,Pancreatic intraepithelial neoplasia (highest grade: PanIN 3),Digestive/Gastrointestinal,71,-,Not Reported,"Stage, TNM","Tumor Grade/Stage: Stage IIB, T3N1M0, Moderately differentiated",-,Not Provided,Not Provided,Not Provided,-,2019-05-16T00:00:00Z
318,PDXNet Consortium Members,WUSTL,WU-0069-T1,K77871,Male,10053571,Melanoma,Ocular melanoma,Skin,54,-,Yes,Stage,"Tumor Grade/Stage: Stage IV Location of known metastases: Brain, Abdomen, Liver, Small Intestine",-,Not Provided,Not Provided,Not Provided,-,2019-05-16T00:00:00Z
319,FY16 IDB/PDX Admistrative Supplement Models,BCM,BCM-0002,K07136,Female,10006190,Invasive breast carcinoma,"Infiltrating ductal, brain met adenocarcinoma type",Breast,NA,NA,Yes,TNM (Pathological),"Tumor Grade/Stage: pT2N1   Location of known metastases:  Pancreas, Brain, Lung","ER+, PR+, Her2-, BRCA1/2 wild type",Not Provided,Black or African American,Not Hispanic or Latino,-,2019-01-01T00:00:00Z
320,FY16 IDB/PDX Admistrative Supplement Models,BCM,BCM-2665,K26406,Female,10006190,Invasive breast carcinoma,"ductal, TNBC",Breast,NA,NA,Yes,"Grade, Stage, TNM (Pathological)","Tumor Grade/Stage: pT2NXMX, Stage IIA, Grade 3, poorly differentiated   Location of known metastases: Contralateral breast, Chest Wall, Lung","ER-, PR-, Her2-",Not Provided,Not Provided,Hispanic or Latino,-,2019-01-01T00:00:00Z
321,FY16 IDB/PDX Admistrative Supplement Models,BCM,BCM-2147 (074-R),K27874,Female,10006190,Invasive breast carcinoma,TNBC,Breast,33,NA,Yes,"Grade, Stage, TNM (Clinical)","Tumor Grade/Stage:  T3N2MX, Stage IIIA, Grade 3, Poorly Differentiated   Location of known metastases: brain, chest wall, lung","ER-, PR-, Her2-, BRCA unknown",Not Provided,Black or African American,Not Hispanic or Latino,-,2019-01-01T00:00:00Z
322,FY16 IDB/PDX Admistrative Supplement Models,BCM,BCM-2277 (172-R),K27874,Female,10006190,Invasive breast carcinoma,TNBC,Breast,33,NA,Yes,"Grade, Stage, TNM (Clinical)","Tumor Grade/Stage:  T3N2MX, Stage IIIA, Grade 3, Poorly Differentiated   Location of known metastases: brain, chest wall, lung","ER-, PR-, Her2-, BRCA unknown",Not Provided,Black or African American,Not Hispanic or Latino,-,2019-01-01T00:00:00Z
323,FY16 IDB/PDX Admistrative Supplement Models,BCM,BCM-0113,K28355,Female,10006190,Invasive breast carcinoma,TNBC,Breast,NA,NA,Yes,"Grade, Stage, TNM (Pathological)","Location of known metastases: bone, liver, chest wall, lymph nodes   Tumor grade/stage: pT1aN3M0 (primary), Stage !!!C (primary), Grade 3 (primary)","ER-, PR-, Her2-, BRCA1/2 wild type",Not Provided,Not Provided,Hispanic or Latino,"Brain metastases: carcinoma NOS, ER-, PR-, Her2-",2019-01-01T00:00:00Z
324,FY16 IDB/PDX Admistrative Supplement Models,BCM,BCM-3107,K36507,Female,10006190,Invasive breast carcinoma,"TNBC, infiltrating ductal",Breast,NA,NA,Not Reported,Grade,Tumor Grade/Stage: Grade 3,"ER-, PR-, Her2-",Not Provided,White,Not Hispanic or Latino,-,2019-01-01T00:00:00Z
325,FY16 IDB/PDX Admistrative Supplement Models,BCM,3104 (043-R),K43197,Female,10006190,Invasive breast carcinoma,infiltrating ductal,Breast,NA,NA,Yes,Grade,Tumor Grade/Stage: Grade 3   Location of known metastases: Pancreas,"ER-, PR-, Her2+",Not Provided,Not Provided,Not Provided,-,2019-01-01T00:00:00Z
326,FY16 IDB/PDX Admistrative Supplement Models,BCM,3143 (057-R),K43197,Female,10006190,Invasive breast carcinoma,infiltrating ductal,Breast,NA,NA,Yes,Grade,Tumor Grade/Stage: Grade 3   Location of known metastases: Pancreas,"ER-, PR-, Her2+",Not Provided,Not Provided,Not Provided,-,2019-01-01T00:00:00Z
327,FY16 IDB/PDX Admistrative Supplement Models,BCM,3472 (176-R),K43197,Female,10006190,Invasive breast carcinoma,infiltrating ductal,Breast,NA,NA,Yes,Grade,Tumor Grade/Stage: Grade 3   Location of known metastases: Pancreas,"ER-, PR-, Her2+",Not Provided,Not Provided,Not Provided,-,2019-01-01T00:00:00Z
328,FY16 IDB/PDX Admistrative Supplement Models,BCM,BCM-0104,K46383,Female,10006190,Invasive breast carcinoma,TNBC,Breast,58,NA,Yes,"Grade, Stage, TNM (Clinical)","Location of known metastases: bone, skin, pleura, lung   Tumor Grade/Stage: T4bN1bM0, Stage IIIb, Grade 3","ER-, PR-, Her2-, Ki67 98%",Not Provided,White,Not Provided,-,2019-01-01T00:00:00Z
329,FY16 IDB/PDX Admistrative Supplement Models,BCM,BCM-0046,K53535,Female,10006190,Invasive breast carcinoma,TNBC,Breast,NA,NA,Not Reported,"Grade, TNM (Clinical)","Tumor Grade/Stage: cT2N1, Grade 3, Poorly differentiated","ER-, PR-, Her2-, BRCA1/2 wild type, Ki67 (75-80%)",Not Provided,Not Provided,Hispanic or Latino,-,2019-01-01T00:00:00Z
330,FY16 IDB/PDX Admistrative Supplement Models,BCM,BCM-3204,K54871,Female,10006190,Invasive breast carcinoma,"TNBC, infiltrating ductal",Breast,NA,NA,Yes,"Stage, TNM (Clinical)","Tumor Grade/Stage: pT3N1MX, Stage 3a   Location of known metastases: Ovary","ER-, PR-, Her2-",Not Provided,White,Not Provided,-,2019-01-01T00:00:00Z
331,FY16 IDB/PDX Admistrative Supplement Models,BCM,BCM-7649,K61702,Female,10006190,Invasive breast carcinoma,TNBC,Breast,44,NA,Yes,"Grade, Stage, TNM (Clinical)","Tumor Grade/Stage: T3N1M0, Stage IIIa, Grade 3   Locations of known metastases: brain, chest wall","BRCA1/2 wild type, ER-, PR-, Her2-, Ki67 100%",Not Provided,White,Hispanic or Latino,-,2019-01-01T00:00:00Z
332,FY16 IDB/PDX Admistrative Supplement Models,BCM,BCM-7821,K66049,Female,10006190,Invasive breast carcinoma,TNBC,Breast,49,NA,Yes,"Grade, Stage, TNM (Pathological)","Tumor Grade/Stage: pT1cN3a, Stage IIIc, Grade 3   Location of known metastases: pleura, chest wall, lung","BRCA1/2 wild type, ER-, PR-, Her2-, Ki67 80%",Not Provided,Black or African American,Not Provided,-,2019-01-01T00:00:00Z
333,FY16 IDB/PDX Admistrative Supplement Models,BCM,BCM-7563,K76984,Female,10006190,Invasive breast carcinoma,Infiltrating duct carcinoma,Breast,45,NA,Not Reported,"Grade, Stage, TNM (Pathological)","Tumor Grade/Stage: pT1cN0, Stage IA, Grade 2","BRCA1/2 wildtype, ER+, PR+, Her2+, Ki67 10%",Not Provided,Black or African American,Not Provided,-,2019-01-01T00:00:00Z
334,FY16 IDB/PDX Admistrative Supplement Models,BCM,BCM-0132,K84690,Female,10006190,Invasive breast carcinoma,TNBC,Breast,58,NA,Not Reported,"Grade, Stage","Tumor Grade/Stage: Stage IIIb, Grade 3","BRCA1/2 wildtype, ER-, PR-, Her2-, Ki67 60%",Not Provided,Black or African American,Not Hispanic or Latino,-,2019-01-01T00:00:00Z
